Renovare Environmental (RENO) 10-Q 29 Jun 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	Jun. 24, 2020
Document and Entity Information
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Entity Registrant Name	BIOHITECH GLOBAL, INC.
Entity Central Index Key	0001590383
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Shell Company	false
Trading Symbol	BHTG
Entity Common Stock, Shares Outstanding		17,437,288
Entity Emerging Growth Company	false
Entity Small Business	true

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue
Total revenue	$ 1,359,341	$ 737,701
Operating expenses
Cost of revenue	25,156	24,537
Selling, general and administrative	1,918,423	2,326,362
Depreciation and amortization	615,202	129,439
Total operating expenses	3,753,291	2,659,004
Loss from operations	(2,393,950)	(1,921,303)
Other expenses
Interest income	(12,267)	0
Interest expense	1,012,291	339,864
Total other expenses	1,000,024	339,864
Net loss	(3,393,974)	(2,261,167)
Net loss attributable to non-controlling interests	(822,677)	(311,701)
Net loss attributable to Parent	(2,571,297)	(1,949,466)
Other comprehensive income (loss)
Foreign currency translation adjustment	(28,699)	1,253
Comprehensive loss	(2,599,996)	(1,948,213)
Net loss attributable to Parent	(2,571,297)	(1,949,466)
Preferred stock dividends	(177,373)	(127,919)
Net loss attributable to common shareholders	$ (2,748,670)	$ (2,077,385)
Net loss per common share - basic and diluted	$ (0.16)	$ (0.14)
Weighted average number of common shares outstanding - basic and diluted	17,376,507	14,816,734
HEBioT (related entity)
Revenue
Revenue	$ 490,132	$ 0
Operating expenses
Cost of revenue	812,427	0
Rental, service and maintenance
Revenue
Revenue	471,093	487,701
Operating expenses
Cost of revenue	260,835	203,203
Equipment sales
Revenue
Revenue	323,116	0
Operating expenses
Cost of revenue	146,404	0
Management advisory and other fees (related party)
Revenue
Revenue	$ 75,000	$ 250,000

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current Assets
Cash	$ 1,934,846	$ 1,847,526
Restricted cash	1,137,714	1,133,581
Accounts receivable, net of allowance for doubtful accounts of $ 98,366 and $170,038 as of March 31, 2020 and December 31, 2019, respectively (related entity $1,860,171 and $1,370,867 as of March 31, 2020 and December 31, 2019, respectively)	2,485,691	2,155,921
Inventory	366,482	467,784
Prepaid expenses and other current assets	172,655	126,357
Total Current Assets	6,097,388	5,731,169
Restricted cash	2,563,978	2,555,845
Equipment on operating leases, net	1,654,753	1,724,998
HEBioT facility, equipment, fixtures and vehicles, net	36,979,350	37,421,333
Operating lease right of use assets	918,585	945,047
License and capitalized MBT facility development costs	8,042,938	8,049,929
Goodwill	58,000	58,000
Other assets	48,849	53,726
Total Assets	56,363,841	56,540,047
Current Liabilities:
Line of credit, net of financing costs of $18,644 and $20,152 as of March 31, 2020 and December 31, 2019, respectively	1,481,356	1,479,848
Advances from related parties	1,410,000	210,000
Accounts payable (related entity $2,654,592 and $2,531,034 as of March 31, 2020 and December 31, 2019, respectively	5,378,697	4,688,339
Accrued interest payable	558,624	1,148,570
Accrued expenses and liabilities	1,871,445	1,926,965
Deferred revenue	98,008	89,736
Customer deposits	6,792	44,792
Note payable	100,000	100,000
Senior Secured Note, net of financing costs of $101,007 and unamortized discounts of $657,415 as of March 31, 2020	4,241,578
Current portion of WV EDA Senior Secured Bonds payable	2,860,000	1,390,000
Current portion of long term debt	4,219	4,605
Total Current Liabilities	18,010,719	11,082,855
Junior note due to related party, net of unamortized discounts of 89,592 and $95,043 as of March 31, 2020 and December 31, 2019, respectively	954,885	949,434
Accrued interest (related party)	1,567,311	1,510,193
WV EDA Senior Secured Bonds payable, net of current portion, and financing costs of $1,747,267 and $1,792,574 as of March 31, 2020 and December 31, 2019, respectively	28,392,733	29,817,426
Senior Secured Note, net of financing costs of $113,268 and unamortized discounts of $726,242 as of December 31, 2019		4,160,490
Non-current lease liabilities	916,973	915,170
Long-term debt, net of current portion	7,126	8,201
Total Liabilities	49,849,747	48,443,769
Series A redeemable convertible preferred stock, 333,401 shares designated and issued, and 145,312 outstanding as of March 31, 2020 and December 31, 2019	726,553	726,553
Commitments and Contingencies
Stockholders' Equity
Preferred Stock, Value, Issued
Common stock, $0.0001 par value, 50,000,000 shares authorized, 17,417,288 and 17,300,899 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively	1,741	1,730
Additional paid in capital	49,953,089	49,597,059
Accumulated deficit	(55,374,103)	(52,785,242)
Accumulated other comprehensive (loss)	(14,439)	(43,138)
Stockholders' equity attributable to Parent	1,264,636	2,024,143
Stockholders' equity attributable to non-controlling interests	4,522,905	5,345,582
Total Stockholders' Equity	5,787,541	7,369,725
Total Liabilities and Stockholders' Equity	56,363,841	56,540,047
Series B Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred Stock, Value, Issued	0	0
Series C Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred Stock, Value, Issued	3,050,142	3,050,142
Series D Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred Stock, Value, Issued	1,505,262	1,505,262
Series E Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred Stock, Value, Issued	698,330	698,330
Series F Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred Stock, Value, Issued	$ 1,444,614	$ 0

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Preferred Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred stock, Designated shares	3,209,210	3,179,120
Preferred Stock, Shares Issued	1,935,648	1,922,603
Preferred Stock, Shares Outstanding	869,226	856,181
Common Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	17,417,288	17,300,899
Common stock, shares outstanding	17,417,288	17,300,899
Debt Issuance Costs, Current, Net	$ 18,644	$ 20,152
Deferred finance cost current	18,644	20,152
Accounts Receivable, Related Parties, Current		1,370,867	$ 1,860,171
Accounts Payable, Related Parties, Current	2,654,592	2,531,034
Allowance for Doubtful Accounts Receivable, Current	98,366	170,038
Junior Notes [Member]
Due to Related Parties, Noncurrent	89,592	95,043
Senior Notes [Member]
Debt Issuance Costs, Noncurrent, Net		113,268
Debt Instrument, Unamortized Discount, Noncurrent		726,242
Debt Issuance Costs, Current, Net	101,007
Debt Instrument, Unamortized Discount, Current	657,415
Deferred finance cost current	101,007
WV EDA SENIOR NOTES [Member]
Debt Issuance Costs, Noncurrent, Net	$ 1,747,267	$ 1,792,574
Series A Redeemable Convertible Preferred [Member]
Preferred stock, Designated shares	333,401	333,401
Preferred Stock, Shares Issued	333,401	333,401
Preferred Stock, Shares Outstanding	145,312	145,312
Series B Convertible Preferred Stock [Member]
Preferred stock, Designated shares	1,111,200	1,111,200
Preferred Stock, Shares Issued	428,333	428,333
Preferred Stock, Shares Outstanding	0	0
Series C Convertible Preferred Stock [Member]
Preferred stock, Designated shares	1,000,000	1,000,000
Preferred Stock, Shares Issued	427,500	427,500
Preferred Stock, Shares Outstanding	427,500	427,500
Series D Convertible Preferred Stock [Member]
Preferred stock, Designated shares	20,000	20,000
Preferred Stock, Shares Issued	18,850	18,850
Preferred Stock, Shares Outstanding	18,850	18,850
Series E Convertible Preferred Stock [Member]
Preferred stock, Designated shares	714,519	714,519
Preferred Stock, Shares Issued	714,519	714,519
Preferred Stock, Shares Outstanding	264,519	264,519
Series F Convertible Preferred Stock [Member]
Preferred stock, Designated shares	30,090	30,090
Preferred Stock, Shares Issued	13,045
Preferred Stock, Shares Outstanding	13,045	0

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net loss	$ (3,393,974)	$ (2,261,167)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation and amortization	615,202	129,439
Amortization of operating lease right of use assets	26,462	24,565
Provision for bad debts	31,119	15,000
Share based employee compensation	280,205	297,749
Interest resulting from amortization of financing costs and discounts	133,355	109,789
Loss resulting from write-off of proposed MBT site		346,654
Changes in operating assets and liabilities	(207,843)	125,322
Net cash used in operating activities	(2,515,474)	(1,212,649)
Cash flow from investing activities:
Purchases of construction in-progress, equipment, fixtures and vehicles	(20,849)	(2,794,824)
MBT facility development costs incurred	(24,509)	(13,600)
MBT facility development costs refunded		66,000
Net cash used in investing activities	(45,358)	(2,742,424)
Cash flows from financing activities:
Proceeds from new line of credit facility	1,495,450	0
Proceeds from the sale of convertible preferred stock units	1,495,450	750,000
Deferred financing costs incurred		(43,941)
Repayments of long-term debt	(1,460)	(2,264)
Related party advances	1,200,000	150,000
Net cash provided by financing activities	2,693,990	853,795
Effect of exchange rate on cash (restricted and unrestricted)	(33,572)	19,851
Net change in cash (restricted and unrestricted)	99,586	(3,081,427)
Cash - beginning of period (restricted and unrestricted)	5,536,952	9,126,380
Cash - end of period (restricted and unrestricted)	$ 5,636,538	$ 6,044,953

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Preferred Stock [Member]Series D Preferred Stock [Member]	Preferred Stock [Member]Series F Preferred Stock [Member]	Preferred Stock [Member]	Common Stock [Member]	Additional Paid in Capital [Member]Series F Preferred Stock [Member]	Additional Paid in Capital [Member]	Accumulated Comprehensive Other Loss [Member]	Accumulated Deficit [Member]	Non-Controlling Equity Interest [Member]	Series D Preferred Stock [Member]	Series F Preferred Stock [Member]	Total
Balance at Dec. 31, 2018			$ 4,540,472	$ 1,480		$ 43,452,963	$ 5,021	$ (44,594,385)				$ 3,405,551
Balance (in shares) at Dec. 31, 2018			992,019	14,802,956
Issuance of preferred stock	$ 750,000									$ 750,000
Issuance of preferred stock (in shares)	7,500
Share-based employee and director compensation						297,749						297,749
Preferred stock dividends								(18,372)				(18,372)
Issuance of restricted stock				$ 2		(2)						0
Issuance of restricted stock (shares)				20,000
Foreign currency translation adjustment							1,253					1,253
Net loss								(1,949,466)				(1,949,466)
Balance at Dec. 31, 2018								(76,890)	$ 6,679,585			6,602,695
Net Loss								(311,701)				(311,701)
Balance at Mar. 31, 2019								(388,591)	6,679,585			6,290,994
Balance at Mar. 31, 2019			$ 5,290,472	$ 1,482		43,750,710	6,274	(46,562,223)				2,486,715
Balance (in shares) at Mar. 31, 2019			999,519	14,822,956
Balance at Dec. 31, 2019			$ 5,253,734	$ 1,730		49,597,059	(43,138)	(52,785,242)				2,024,143
Balance (in shares) at Dec. 31, 2019			710,869	17,300,899
Issuance of preferred stock		$ 1,444,614			$ 50,836						$ 1,495,450
Issuance of preferred stock (in shares)		13,045
Share-based employee and director compensation				$ 10								280,205
Share-based employee and director compensation (in shares)				102,500
Share-based employee and director compensation						280,195
Preferred stock dividends				$ 1		24,999		(17,564)				7,436
Preferred stock dividends (in shares)				13,889
Foreign currency translation adjustment							28,699					28,699
Net loss								(2,571,297)				(2,571,297)
Balance at Dec. 31, 2019								(2,734,003)	8,079,585			5,345,582
Net Loss								(822,677)				(822,677)
Balance at Mar. 31, 2020								(3,556,680)	$ 8,079,585			4,522,905
Balance at Mar. 31, 2020			$ 6,698,348	$ 1,741		$ 49,953,089	$ (14,439)	$ (55,374,103)				$ 1,264,636
Balance (in shares) at Mar. 31, 2020			723,914	17,417,288

Basis of Presentation and Going

Basis of Presentation and Going Concern	3 Months Ended
	Mar. 31, 2020
Basis Of Presentation And Going Concern
Basis of Presentation and Going Concern	Note 1. Basis of Presentation and Going Concern Nature of Operations - BioHiTech Global, Inc. (the “Company” or “BioHiTech”) through its wholly-owned and its controlled subsidiaries provides cost-effective and sustainable environmental management solutions. Our cost-effective technology solutions include the patented processing of municipal solid waste into a valuable renewable fuel, biological disposal of food waste on-site, and proprietary real-time data analytics tools to reduce food waste generation. Our solutions enable businesses and municipalities of all sizes to lower disposal costs while having a positive impact on the environment. When used individually or in combination, our solutions lower the carbon footprint associated with waste transportation and can reduce or virtually eliminate landfill usage. In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) as a pandemic which continues to spread throughout the United States and globally. The Company is monitoring the near term and longer term impacts of COVID-19 and the related business and travel restrictions and changes to behavior intended to reduce its spread, and its impact on operations, financial position, cash flows, inventory, supply chains, purchasing trends, customer payments, and the industry in general, in addition to the impact on its employees. Due to the rapid development and fluidity of this situation, the magnitude and duration of the pandemic and its impact on the Company's operations, liquidity and financial performance will depend on certain developments, including duration, spread and reemergence of the outbreak, its impact on our customers, supply chain partners and employees, and the range of governmental and community reactions to the pandemic, which are uncertain and cannot be fully predicted at this time. As a result of COVID-19 the implementation of the Company’s contract with Carnival Corporation has been delayed and the operations of some customers in the restaurant and hospitality industries have been temporarily interrupted due to governmental actions. For certain existing restaurant and hospitality customers, the Company has provided a deferral of recurring rental payments for a short time and have modified the rental agreements to extend the term by the period deferred. These actions have placed a strain on the Company’s cash flows resulting in the Company executing on cost controls and cash preservation practices that have included reducing executive cash compensation, laying off non- essential employees, limiting expenses and disbursements, as well as extending vendor payments. Basis of Presentation - The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned and controlled subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10‑Q and Article 8 of Regulation S-X. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. It is management’s opinion, however, that the accompanying condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, and the elimination of intercompany accounts and transactions which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying condensed consolidated financial statements should be read in conjunction with the Company’s financial statements for the year ended December 31, 2019, which contains the audited financial statements and notes thereto, for the years ended December 31, 2019 and 2018 included within the Company’s Form 10‑K filed with the Securities and Exchange Commission (“SEC”) on May 22, 2020. The financial information as of December 31, 2019 presented hereto is derived from the audited consolidated financial statements presented in the Company’s audited consolidated financial statements for the year ended December 31, 2019. The interim results for the three months ended March 31, 2020 is not necessarily indicative of the results to be expected for the year ending December 31, 2020 or for any future interim periods. As of March 31, 2020 and December 31, 2019, the Company's active wholly-owned subsidiaries were BioHiTech America, LLC, BioHiTech Europe Limited, BHT Financial, LLC and E.N.A. Renewables LLC, and its controlled subsidiary was Refuel America LLC (60)% and its wholly-owned subsidiaries Apple Valley Waste Technologies Buyer, Inc., Apple Valley Waste Technologies, LLC, New Windsor Resource Recovery LLC and Rensselaer Resource Recovery LLC and its controlled subsidiary Entsorga West Virginia LLC (88.7%, 88.7%and 78.2% as of March 31, 2020, December 31, 2019 and March 31, 2019, respectively). As each of these subsidiaries operate as environmental-based service companies, we did not deem segment reporting necessary. Reclassifications to certain prior period amounts have been made to conform to current period presentation. These reclassifications have no effect on previously reported net loss. Going Concern and Liquidity - For the three months March 31, 2020, the Company had a consolidated net loss of $3,393,974, incurred a consolidated loss from operations of $2,393,950 and used net cash in consolidated operating activities of $2,515,474. At March 31, 2020, consolidated total stockholders’ equity amounted to $5,787,541, consolidated stockholders’ equity attributable to parent amounted to $1,264,636 and the Company had a consolidated working capital deficit of $11,913,331. While the Company had not met certain of its senior secured note’s financial covenants as of March 31, 2020 (Note 6), subsequent to that date the Company has favorably renegotiated those covenants and has received a waiver for such non-compliance through June 30, 2020 as it continues to negotiate further extension of that waiver. Despite its current compliance under the waiver, until such time as the Company regains compliance or receives a waiver of such covenants for a year beyond the balance sheet date, under current GAAP accounting rules the senior secured notes amounting to $4,241,578 have been classified as current debt. The Company does not yet have a history of financial profitability. The Company does not have firm commitments to fund its future operational and strategic plans although it is presently in the process of raising additional debt for general operations and to support its leasing activities. The Company has used its Shelf Registration on Form S-3 during September 2019 to raise net proceeds of $3,035,557 through a confidentially marketed public offering of common shares, has raised $1,495,450 through a private convertible preferred stock offering in March 2020 and subsequent to March 31, 2020 one of the Company’s subsidiaries was funded $421,300 on May 13, 2020 through the Paycheck Protection Program.. There is no assurance that the Company will be able to raise sufficient capital or debt to sustain operations or to pursue other strategic initiatives or that such financing will be on terms that are favorable to the Company. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. The ability of the Company to continue as a going concern is dependent on management’s further implementation of the Company’s on-going and strategic plans, which include continuing to raise funds through equity and/or debt raises. Should the Company be unable to raise adequate funds, certain aspects of the on-going and strategic plans may require modification.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies The condensed consolidated financial statements have been prepared by the Company without audit in accordance with the rules and regulations of the SEC and should be read in conjunction with our audited financial statements for the year ended December 31, 2019. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted as permitted by the SEC, although we believe the disclosures that are made are adequate to make the information presented herein not misleading. Recent Accounting Pronouncements: The Company has not implemented any recent accounting pronouncements during the three months ended March 31, 2020. The Company has not implemented the following accounting standard: In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments . This standard requires an allowance to be recorded for all expected credit losses for certain financial assets. The new standard introduces an approach, based on expected losses, to estimate credit losses on certain types of financial instruments. ASU 2016-13 is effective for public companies for interim and annual period beginning December 15, 2020. Entities are required to apply the standard's provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company has not yet adopted this update and is currently evaluating the effect this new standard will have on its financial condition and results of operations. There have been no other recent accounting pronouncements or changes in accounting pronouncements that have been issued but not yet adopted that are of significance, or potential significance, to the Company.

Equipment on Operating Leases,

Equipment on Operating Leases, net	3 Months Ended
	Mar. 31, 2020
Equipment on Operating Leases, net
Equipment on Operating Leases, net	Note 3. Equipment on Operating Leases, net Equipment on operating leases consist of the following: March 31, December 31, 2020 2019 Leased equipment $ 3,175,933 $ 3,138,951 Less: accumulated depreciation (1,521,180) (1,413,953) Total Equipment on Operating Leases, net $ 1,654,753 $ 1,724,998 The Company is a lessor of digester units under non-cancellable operating lease agreements expiring through September 2025. These leases generally have terms of three to five years and do not contain stated extension periods or options for the lessee to purchase the underlying assets. At the end of the leases, the lessee may enter into a new lease or return the asset, which would be available to the Company for releasing. During the three months ended March 31, 2020 and 2019, revenue under the agreements, which is included in rental, service and maintenance revenue, amounted to $386,254 and $341,665, respectively. During the three months ended March 31, 2020 and 2019, depreciation expense included in rental, service and maintenance expense, amounted to $115,866 and $101,502, respectively. The minimum future estimated contractual payments to be received under these leases as of March 31, 2020 is as follows: Year ending December 31, 2020, remaining period $ 1,024,508 2021 990,315 2022 719,049 2023 457,898 2024 and thereafter 181,725 $ 3,373,495

HEBioT facility, equipment, fix

HEBioT facility, equipment, fixtures and vehicles, net	3 Months Ended
	Mar. 31, 2020
HEBioT facility, equipment, fixtures and vehicles, net
HEBioT facility, equipment, fixtures and vehicles, net	Note 4. HEBioT facility, equipment, fixtures and vehicles, net HEBioT facility, equipment, fixtures and vehicles, net consist of the following: March 31, December 31, 2020 2019 HEBioT facility $ 31,142,974 $ 31,142,974 HEBioT equipment 7,407,096 7,388,896 Computer software and hardware 115,076 112,629 Furniture and fixtures 48,196 48,196 Vehicles 50,319 50,319 38,763,661 38,743,014 Less: accumulated depreciation and amortization (1,784,311) (1,321,681) Total HEBioT facility, equipment, fixtures and vehicles, net $ 36,979,350 $ 37,421,333

MBT Facility Development and Li

MBT Facility Development and License Costs	3 Months Ended
	Mar. 31, 2020
MBT Facility Development and License Costs
MBT Facility Development and License Costs	Note 5. MBT Facility Development and License Costs MBT Facility Development and License Costs consist of the following: March 31, December 31, 2020 2019 MBT Projects Survey and engineering 259,738 235,229 Technology Licenses Future site 6,019,200 6,019,200 Martinsburg, West Virginia, net of $126,000 and $94,500 of amortization as of March 31, 2020 and December 31, 2019 1,764,000 1,795,500 Total Technology Licenses 7,783,200 7,814,700 Total MBT Facility Development and License Costs $ 8,042,938 $ 8,049,929 MBT Facility Development Costs - During 2018, the Company commenced initial development of a project in Rensselaer, NY. As of March 31, 2020, the Company has received local permits and has filed the required state permit applications, which are undergoing review by the New York State Department of Environmental Conservation. Technology License Agreement – Future Facility – The royalty payment for the license amounted to $6,019,200. This Technology License Agreement can be utilized at a future project and will be amortized once the facility is in operation. Technology License Agreement – Martinsburg, West Virginia – In connection with the 2018 acquisition accounting applied to Entsorga West Virginia acquisition, the License Agreement was valued at $1,890,000. During the three months ending March 31, 2020 amounted to $31,500. Amortization of the License Agreement commenced with the facility becoming operational on March 31, 2019 and there was no amortization for the three months ended Mach 31, 2019.

Line of Credit, Promissory Note

Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts	3 Months Ended
	Mar. 31, 2020
Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts
Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts	Note 6. Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts consist of the following: March 31, 2020 December 31, 2019 Related Related Total Party Total Party Line of credit $ 1,481,356 $ — $ 1,479,848 $ — Senior secured promissory note 4,241,578 — 4,160,490 — Junior promissory note 954,885 954,885 949,434 949,434 Note payable 100,000 — 100,000 — Advances from related parties (See Note 14 Related Parties) 1,410,000 1,410,000 210,000 210,000 Long term debt - current and long-term portion 11,345 — 12,806 — Line of Credit — The Credit Agreement and Note with Comerica does not have any financial covenants, carries interest at the rate of 3%, plus either the Comerica prime rate or a LIBOR-based rate, (5.58% and 5.71% as of March 31, 2020 and December 31, 2019, respectively) and matured on January 1, 2020, which was subsequently extended to March 31, 2020 and remains outstanding as of the date of this filing. The Company expects to obtain an amended agreement through the remainder of 2020. The line of credit is secured by the assets of BHT Financial, LLC and is personally guaranteed by the Company’s Chief Executive Officer, Frank E. Celli and James D. Chambers, a director. Michaelson Senior Secured Term Promissory Financing –Company and several of the Company’s wholly-owned subsidiaries have a Note Purchase and Security Agreement with Michaelson Capital Special Finance Fund II, L.P. (“ MCSFF ”) for a senior secured term promissory note in the principal amount of $5,000,000 (the “Note”). The Note is not convertible and accrues interest at the rate of 10.25% per annum. The Note provides for certain financial covenants that were not met as of March 31, 2020. While the Company had not met certain of its senior secured note’s financial covenants as of March 31, 2020, subsequent to that date the Company has favorably renegotiated those covenants and has received a waiver for such non-compliance through June 30, 2020 as it continues to negotiate further extension of that waiver. Despite its current compliance under the waiver, until such time as the Company regains compliance or receives a waiver of such covenants for a year beyond the balance sheet date, under current GAAP accounting rules the senior secured notes amounting to $4,241,578 have been classified as current debt. As of December 31, 2019 those certain financial covenants were not met and a waiver of such was granted by MCSFF through January 1, 2021 with the condition that the parties negotiate new financial covenants, which were concluded subsequent to March 31, 2020. As of December 31, 2019, the Note has been classified based on the contractual repayment schedule. For purposes of the following maturity schedule, as the Company believes that it will achieve compliance with the revised financial covenants and MCSFF has a history of waiving non-compliance with financial covenants, the maturities have been presented based upon the contractual repayment terms in effect as of March 31, 2020. The Note is contractually scheduled to be repaid in eight, equal, quarterly installments of $625,000 commencing on May 15, 2021 and ending February 2, 2023 (the “Maturity Date”). Note Payable - As of March 31, 2020 and December 31, 2019, the note, with interest at 10%, had a remaining balance outstanding of $100,000 and matured on January 1, 2020 and remains outstanding as of the date of this filing. The Company expects to amend the agreement to extend the maturity date through the remainder of 2020. Contractual Maturities of Senior Secured, Junior Promissory, Notes Payable and Long Term Debt — As of March 31, 2020, excluding discounts and deferred finance costs, which are being amortized as interest expense, are as follow: Non- Year Ending December 31, Amortizing Amortizing Total 2020 (Remaining) $ 3,144 $ 100,000 $ 103,144 2021 4,380 1,875,000 1,879,380 2022 3,821 2,500,000 2,503,821 2023 — 625,000 625,000 2024 and thereafter — 1,044,477 1,044,477 Total $ 11,345 $ 6,144,477 $ 6,155,822

Entsorga West Virginia, LLC WVE

Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds	3 Months Ended
	Mar. 31, 2020
Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds
Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds	Note 7. Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds During 2016, Entsorga West Virginia LLC (the “Borrower”) was issued $25,000,000 in Non-Recourse Solid Waste Revenue Bonds from the West Virginia Economic Development Authority (the “WVEDA Bonds”). The WVEDA Bonds were issued in two series with one for $7,535,000 bearing interest at 6.75% per annum with a maturity date of February 1, 2026 and the second for $17,465,000 bearing interest at 7.25% per annum with a maturity of February 1, 2036. Both series were issued at par. The 2026 series was payable with interest-only payments through February 1, 2019 then annual payments of principal and semi-annual payments of interest through maturity. The 2036 series is payable with interest-only payments through February 1, 2019 then annual payments of principal and semi-annual payments of interest through maturity. Repayment of principal is by way of sinking fund. During 2018, the 2016 Indenture Trust and Loan Agreement were amended and restated effective November 1, 2018. These amendments provided for a third series of bonds amounting to $8,000,000 bearing interest at 8.75% per annum with a maturity date of February 1, 2036, with special event triggered pre-payment requirements. This series was issued at par. The 2036 series is payable with interest-only payments through February 1, 2020 then annual payments of principal and semi-annual payments of interest through maturity. Repayment is by way of sinking fund. The outstanding balance of the WVEDA Bonds as of March 31, 2020 and December 31, 2019 is $33,000,000, which is presented net of unamortized debt issuance costs amounting to $2,207,759 as of March 31, 2020 and December 31, 2019, less associated amortization of $460,492 and $415,185 as of March 31, 2020 and December 31, 2019, respectively, which includes amortization prior to the Company’s control acquisition in 2018. Amortization is calculated on the effective interest method, which is included in interest expense in the accompanying consolidated statements of operations and comprehensive loss. The loan agreement and indenture of trust place restrictions on the Borrower and its members regarding additional encumbrances on the property, disposition of the property, and limitations on equity distributions. The loan agreement also provides for financial covenants, which became effective on September 30, 2019. As of March 31, 2020 and December 31, 2019 the Company was not in compliance with all of the financial covenants and subsequently was in default on a principal repayment due in February 2020 and has entered into a forbearance agreement with the bond trustee that provides, they will not accelerate the repayment of the bonds due to the defaults through April 2, 2021. The future sinking fund payments by the Borrower as of March 31, 2020 are as follow: 2016 Issue 2016 Issue 2018 Issue Year Ending December 31, 2026 Series 2036 Series 2036 Series Total 2020 (remaining) $ 1,160,000 $ — $ 230,000 $ 1,390,000 2021 1,215,000 — 255,000 1,470,000 2022 900,000 — 275,000 1,175,000 2023 965,000 — 300,000 1,265,000 2024 and thereafter 3,295,000 17,465,000 6,940,000 27,700,000 Total $ 7,535,000 $ 17,465,000 $ 8,000,000 $ 33,000,000 In connection with the November 1, 2018 amendment and restatement of the WVEDA Bonds, Comerica Bank issued a standby letter of credit in the amount of $1,250,000 for the benefit of the WVEDA Bond trustee that is collateralized by the Company’s cash.

Equity and Equity Transactions

Equity and Equity Transactions	3 Months Ended
	Mar. 31, 2020
Equity and Equity Transactions
Equity and Equity Transactions	Note 8. The Company has 50,000,000 shares of its $0.0001 par common stock and 10,000,000 shares of blank check preferred stock authorized by its shareholders. As of March 31, 2020 and December 31, 2018, 17,417,288 and 17,300,899 shares of common stock have been issued; and 3,209,210 and 3,179,120 shares, respectively, of preferred stock have been designated in five series of shares, which have a total of $1,192,619 in accumulated, but undeclared preferential dividends as of March 31, 2020, as follows: Designated Par Stated Shares Outstanding Designation Shares Value Value March 31, 2020 December 31, 2019 Series A Convertible Preferred Stock 333,401 $ 0.0001 $ 5.00 145,312 145,312 Series B Convertible Preferred Stock 1,111,200 0.0001 $ 5.00 — — Series C Convertible Preferred Stock 1,000,000 0.0001 $ 10.00 427,500 427,500 Series D Convertible Preferred Stock 20,000 0.0001 $ 100.00 18,850 18,850 Series E Convertible Preferred Stock 714,519 0.0001 $ 2.64 264,519 264,519 Series F Convertible Preferred Stock 30,090 0.0001 $ 115.00 13,045 — Under the terms of the Company’s senior lender agreements, the Company is restricted from paying dividends in cash, but is allowed to pay dividends in common stock. The Company, since its merger in 2015, has not paid any cash or stock dividends on common stock. The consolidated financial statements include less than 100% owned and controlled subsidiaries and include equity attributable to non-controlling interests that take the form of the underlying legal structures of the less than 100% owned subsidiaries. Entsorga West Virginia LLC through its limited liability agreement and the agreements related to its WVEDA Bonds have restrictions on distributions to and loans to owners while the WVEDA Bonds are outstanding. Series F Convertible Preferred Stock - On March 9, 2020 the Company designated a new series of preferred stock and subsequently on March 18, 2020 had an initial closing of $1,500,000 on 13,045 shares of the new series of preferred stock and 178,597 common stock warrants and are presented net of $50,836 in warrant valuations and $4,550 in issuance costs. The newly designated series, the Series F Redeemable, Convertible Preferred Stock (the “Sr. F Preferred Stock”) is comprised of 30,090 shares with a par value of $0.0001 per share and a stated value per share of $115.00 that has a dividend rate of 9%. The Sr. F Preferred Stock is convertible by the holder at any time at a conversion rate of $2.10, subject to certain antidilution adjustments and is redeemable by the Company after 24 months at its stated value, plus any outstanding accrued or accumulated dividends for cash, or if the Company's common stock is trading over $3.00 per share and has daily trading volume of over 50,000 shares, for the Company's common stock at the conversion rate in effect at the time. In connection with the offering of the Sr. F Preferred Stock, the Company also issued 178,597 warrants that expire in five years to acquire the Company's common stock at $2.30 per share. Warrants – In connection with the issuance of convertible debt, preferred and common stock and in connection with services provided, the Company has the 4,852,858 warrants to acquire the Company’s common stock outstanding as of March 31, 2020, as follows: Weighted Expiring During the Year Exercise Price Average Exercises Ending December 31, Warrant Shares per Share Price per Share 2020 22,860 $3.50 $3.50 2021 1,768,516 $1.80 to $3.75 $3.25 2022 1,699,861 $1.80 to $5.00 $2.60 2023 740,749 $1.80 $1.80 2024 385,945 $1.80 $1.80 2025 234,927 $2.25 to $2.30 $2.29 The following table summarizes the outstanding warrant activity for the three months ended March 31, 2020: Outstanding, January 1, 2020 4,674,261 Issued as a result of Series F Convertible Preferred Stock offering 178,597 Exercised — Expired — Outstanding, March 31, 2020 4,852,858

Equity Incentive Plans

Equity Incentive Plans	3 Months Ended
	Mar. 31, 2020
Equity Incentive Plans
Equity Incentive Plans	Note 9. Equity Incentive Plans The Company has two equity incentive plans: 2015 Equity Incentive Plan — During 2015, the Company established the BioHiTech Global, Inc. 2015 Equity Incentive Plan, which is available to eligible employees, directors, consultants and advisors of the Company and its affiliates. The plan allows for the granting of incentive stock options, nonqualified stock options, reload options, stock appreciation rights, and restricted stock representing up to 750,000 shares. The Plan is administered by the Compensation Committee of the Board of Directors. 2017 Executive Incentive Plan — During 2017, the shareholders approved the 2017 Executive Incentive Plan, which is available to eligible employees, directors, consultants and advisors of the Company and its affiliates. The plan allows for the granting of incentive stock options, nonqualified stock options, reload options, stock appreciation rights, and restricted stock representing up to 1,000,000 shares. The Plan is administered by the Compensation Committee of the Board of Directors. Effective January 30, 2020, the Company granted nonqualified options for 155,450 shares and 269,060 restricted stock units. The options granted had a fair value of $162,959 using the Black-Scholes option pricing model with the following assumptions: risk-free interest rate of 1.44%, expected dividend yield of 0%, expected volatility of 49.24% and expected term in years of from 1.00 to 2.92 years. The restricted stock units had a value of $538,120 based on the market value on the date of the grants and a weighted average vesting period of 0.75 years. Compensation expense related to stock options and restricted stock for the three months ended March 31, was: 2020 2019 Stock options $ 48,460 $ 58,388 Restricted stock 231,745 239,361 Total $ 280,205 $ 297,749 Compensation expense related to stock options and restricted stock for the three months ended March 31, are reflected in the following captions within operating expenses in the condensed consolidated statements of operations and comprehensive loss: 2020 2019 Rental, service and maintenance $ 3,317 $ 5,755 Selling, general and administrative 276,888 291,994 Total $ 280,205 $ 297,749 The following summarizes the Company’s stock option activity for the three months ended March 31, 2020: Weighted Average Weighted Remaining Average Contractual Number of Exercise Life Aggregate Options Price (in Years) Intrinsic Value Outstanding – January 1, 2020 363,826 $ 3.71 7.34 — Granted 155,450 — — Exercised — — — — Forfeited, Canceled or Expired — — — — Outstanding – March 31, 2020 519,276 $ 3.20 7.91 — Exercisable – March 31, 2020 241,651 $ 3.67 6.59 — The following summarizes the Company’s restricted stock unit activity for the three months ended March 31, 2020: Balance, January 1, 2020 291,730 Grants 269,060 Forfeited — Vested — Balance, March 31, 2020 560,790

Revenue

Revenue	3 Months Ended
	Mar. 31, 2020
Revenue
Revenue	Note 10. Revenue The Company recognizes revenue as services are performed or products are delivered and generally recognize revenue for the gross amount of consideration received as we are generally the primary obligor (or principal) in our contracts with customers as we hold complete responsibility to the customer for contract fulfillment. We record amounts collected from customers for sales tax on a net basis. Disaggregation of Revenue — The disaggregation of revenue for the three months ended March 31, is as follows: 2020 2019 Revenue Type: Rental of digesters $ 386,254 $ 341,665 Services 601,433 372,975 Product sales 371,654 23,061 Total Revenue $ 1,359,341 $ 737,701

Risk Concentrations

Risk Concentrations	3 Months Ended
	Mar. 31, 2020
Risk Concentrations
Risk Concentrations	Note 11. Risk Concentrations The Company operates as a single segment on a worldwide basis through its subsidiaries, resellers and independent sales agents. Gross revenues and net non-current tangible assets on a domestic and international basis are as follows: United States International Total 2020: Revenue, for the three months ended March 31, 2020 $ 1,225,910 $ 133,431 $ 1,359,341 Non-current tangible assets, as of March 31, 2020 38,330,741 316,862 38,647,603 2019: Revenue, for the three months ended March 31, 2019 $ 641,646 $ 96,055 $ 737,701 Non-current tangible assets, as of December 31, 2019 38,803,333 355,825 39,159,658 Credit risk — Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and accounts receivable. The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institutions. At times, the Company’s cash may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation (“FDIC”) in the USA and the Financial Conduct Authority (“FCA”) in the UK insurance limits. Through March 31, 2020, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Major customers — During the three months ended March 31, 2020, one customer represented at least 10% of revenues, accounting for 35.9% (Gold Medal Group, LLC, an affiliated entity, “GMG”) of revenues. During the three months ended March 31, 2019, one customer represented at least 10% of revenues, accounting for 34.6% (GMG). As of March 31, 2020 one customer represented at least 10% of accounts receivable, accounting for 74.8% (GMG) of accounts receivable. As of December 31, 2019 one customer represented at least 10% of accounts receivable, accounting for 58.9% (GMG) of accounts receivable. Vendor concentration — During the three months ended March 31, 2020, one vendor represented at least 10% of costs of revenue, accounting for 24.5% (GMG). During the three months ended March 31, 2019, no vendors represented at least 10% of the combined cost of revenues. As of March 31, 2020, excluding construction payables and other professional fees, one vendor represented at least 10% of accounts payable accounting for 45.5% (GMG) of accounts payable. As of December 31, 2019, one vendor represented at least 10% of accounts payable accounting for 54.4% (GMG) of accounts payable. Affiliate relationship — GMG owns a 40% interest in Refuel America, LLC, a consolidated subsidiary of the Company. GMG’s subsidiaries, which are not consolidated in the Company’s financial statements have several business relationships with the Company and its subsidiaries that result in revenues and expenses noted above. See Note 14. Related Party Transactions.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies
Commitments and Contingencies	Note 12. Commitments and Contingencies During the three months ended March 31, 2020 the Company was involved in the following legal matters. On February 7, 2018, Lemartec Corporation (“Lemartec”) filed a complaint against the Company in the United States District Court for the Northern District of West Virginia arising out of the construction of the Company’s resource recovery facility in Martinsburg, West Virginia alleging breach of contract and unjust enrichment. The Company has filed its answer and counterclaims for damages against Lemartec and cross claims against Lemartec’s performance bond surety, Philadelphia Indemnity Insurance Company. The trial was scheduled to begin in August 2020. Prior to the start of the trial, on March 12, 2020 the Company entered into a settlement agreement that detailed the full and final mutual release. The settlement agreement provides that the Company pay Lemartec $775,000 in installments of $475,000 within 60 days of the execution of the settlement agreement and $25,000 each month thereafter for 12 months. The Company's consolidated financial statements as of December 31, 2019 reflects this liability given the nature of the subsequent event. It is management’s opinion that the resolution of this known claim will not materially affect the Company’s future financial position, results of operations, or cash flows. From time to time, the Company may be involved in other legal matters arising in the ordinary course of business. While the Company believes that such matters are currently not material, there can be no assurance that matters arising in the ordinary course of business for which the Company is, or could be, involved in litigation, will not have a material adverse effect on its business, financial condition or results of operations

Leases

Leases	3 Months Ended
	Mar. 31, 2020
Leases
Leases	Note 13. Leases Effective January 1, 2019, the Company implemented Accounting Standards Codification 842, Leases. The Company utilized the optional transition method to assess the impact of this guidance on the Company’s financial statements and related disclosures, including the increase in the assets and liabilities on our balance sheet from lessee perspective. The Company completed a comprehensive review of its leases that were impacted by the new guidance. As part of the adoption, the Company elected the ‘package of practical expedients,’ which permits the Company not to reassess under the new standard the Company’s prior conclusions about lease identification, lease classification and initial direct costs, therefore the Company did not restate prior comparative periods. The Company rents its headquarters and attached warehousing space from a related party (see Note 14) and has a land lease relating to the Martinsburg, WV HEBioT facility under operating leases. The HEBioT facility land lease has an initial term of 30 years, plus four 5‑year extensions. For purposes of our determination of lease liabilities, extensions were not included. As the leases do not provide an implicit rate, the Company used incremental borrowing rates in determining the present value of lease payments. For the HEBioT facility land lease a rate of 11% was utilized and a rate of 10.25% was used on the other leases. The current portion of the lease liabilities of $121,510 is included in accrued expenses and liabilities. Total lease costs under operating leases amounted to $55,356 and $67,532 for the three months ended March 31, 2020 and 2019, respectively. Maturities of lease liabilities under these leases, which have a weighted average remaining term of 25.6 years, as of March 31, 2020 is: Year Ending December 31, 2020 (remaining) $ 95,521 2021 109,000 2022 113,000 2023 113,000 2024 and thereafter 2,980,750 Total lease payments 3,411,271 Less imputed interest (2,372,788) Present value of lease liabilities $ 1,038,483 The Company operating cash flows for operating leases amounting to $51,406 and $46,034 for the three months ended March 31, 2020 and 2019, respectively.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2020
Related Party Transactions
Related Party Transactions	Note 14. Related Party Transactions Related parties include Directors, Senior Management Officers, and shareholders, plus their immediate family, who own a 5% or greater ownership interest at the time of a transaction. Related parties also include GMG and its subsidiaries as a result of its 40% interest in Refuel America, LLC ("Refuel"), a consolidated entity of the Company. During 2018 GMG acquired as regional waste management entity, Apple Valley Waste (“AVW”), with operations located in West Virginia, Maryland and Pennsylvania. As part of this acquisition, GMG also acquired AVW's interests in EWV that were contributed to Refuel. Prior to GMG’s acquisition of AVW and the Company’s investments and control acquisition of EWV, in order for EWV to receive the proceeds from the Entsorga West Virginia, LLC WVEDA Non-Recourse Solid Waste Disposal Revenue Bonds , EWV and AWV had entered into several agreements relating to business services, solid waste delivery and disposal. The table below presents the face amount of direct related party assets and liabilities and other transactions or conditions as of or during the periods indicated. March 31, December 31, 2020 2019 Assets: Accounts receivable (a) (b) $ 1,860,171 $ 1,370,867 Intangible assets, net, included in other assets (c) 35,349 40,399 Liabilities: Accounts payable (c) (d) (e) (f) 2,654,592 2,531,034 Accrued interest payable 101,907 46,796 Long term accrued interest (g) 1,567,311 1,510,193 Advance from related party (h) 1,410,000 210,000 Junior promissory note (g) 954,885 949,434 Other: Line of credit guarantee (i) 1,481,356 1,479,848 The table below presents direct related party expenses or transactions for the three months ended March 31, 2020 and 2019. Compensation and related costs for employees of the Company are excluded from the table below. 2020 2019 Management advisory and other fees (a) $ 75,000 $ 250,000 HEBioT revenue (b) 406,958 — Operating expenses - HEBioT (d) 298,803 — Operating expenses - Selling, general and administrative (e) 25,156 24,537 Operating expenses - Selling, general and administrative (c) (f) 110,650 18,750 Interest expense 97,948 63,628 Debt guarantee fees (i) 16,875 16,875 Summary notes: a - Management Advisory Fees f - Business Services Fees b - HEBioT Disposal Revenues g - Junior Promissory Note c - Distribution Agreement h - Advances from Related Parties d - Disposal costs i - Line of Credit e - Facility Lease Advances from Related Parties - The Company’s Chief Executive Officer (the “Officer”) on occasion advances the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. During the three months ended March 31,2020 the Officer advanced $1,000,000 to the Company. There are no financial covenants related to this advance and there are no formal commitments to extend any further advances. In addition, during the three months ended March 31, 2020 another officer advanced $200,000 to the Company.

Supplemental Consolidated State

Supplemental Consolidated Statement of Cash Flows Information	3 Months Ended
	Mar. 31, 2020
Supplemental Consolidated Statement of Cash Flows Information
Supplemental Consolidated Statement of Cash Flows Information	Note 15. Supplemental Consolidated Statement of Cash Flows Information Changes in non-cash operating assets and liabilities, as well as other supplemental cash flow disclosures for the three months ended March 31, are as follows. 2020 2019 Changes in operating assets and liabilities: Accounts receivable $ (324,890) $ 48,266 Inventory 31,981 76,930 Prepaid expenses and other assets (25,989) (36,508) Accounts payable 672,061 3,088,732 Accrued interest payable (525,392) (399,764) Accrued expenses (9,591) (2,668,827) Deferred revenue 11,977 12,142 Customer deposits (38,000) 4,351 Net change in operating assets and liabilities $ (207,843) $ 125,322 Supplementary cash flow information: Cash paid during the periods for: Interest $ 1,387,402 $ 1,082,526 Income taxes — — Supplementary Disclosure of Non-Cash Investing and Financing Activities: Transfer of inventory to leased equipment $ 67,604 $ 6,884 Accrual of Series A preferred stock dividends 17,564 18,372 Payment of Series A preferred stock dividends in common stock 25,000 — Reconciliation of Cash and Restricted Cash: Cash $ 1,934,846 $ 1,374,564 Restricted cash (current) 1,137,714 2,137,456 Restricted cash (non-current) 2,563,978 2,532,933 Total cash and restricted cash at the end of the period $ 5,636,538 $ 6,044,953

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2020
Subsequent Events
Subsequent Events	Note 16. Subsequent Events The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the financial statements were available for issuance are disclosed as subsequent events, while the financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, except as disclosed within the footnotes or as discussed below, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements. On January 30, 2020 the Chief Executive Officer and another officer advanced $1,050,000 and $200,000 to the Company, which the Company repaid $275,000 and $200,000 on April 27, 2020, respectively. The Company has applied for funds under the Paycheck Protection Program in May 2020 for one of its subsidiaries. The application for these funds requires the Company to, in good faith, certify that the current economic uncertainty made the loan request necessary to support the ongoing operations of the Company. This certification further requires the Company to take into account its current business activity and its ability to access other sources of liquidity sufficient to support ongoing operations in a manner that is not significantly detrimental to the business. The application amounting to $421,300 was approved and was funded on May 13, 2020. The forgiveness of the loan attendant to these funds, is dependent on the Company qualifying for the forgiveness of such loan based on its future adherence to the forgiveness criteria. On April 6, 2020 the Company closed on an additional $65,000 on 566 shares of the Series F of preferred stock and 7,750 common stock warrants. Effective April 1, 2020 the Company and GMG mutually agreed to reduce the scope and its annual fee related to the management agreement in place from $300,000 to $100,000 per year.

Condensed Consolidating Financi

Condensed Consolidating Financial Information	3 Months Ended
	Mar. 31, 2020
Condensed Consolidating Financial Information
Condensed Consolidating Financial Information	Note 17. Condensed Consolidating Financial Information The WVEDA Solid Waste Disposal Revenue Bond obligations of Entsorga West Virginia LLC are not guaranteed by its members, including the Company, however the membership interests of Entsorga West Virginia LLC are pledged, and the debt agreements provide restrictions prohibiting distributions to the members, including equity distributions or providing loans or advances to the members. The following pages present the Company’s consolidating balance sheet as of March 31, 2020 and December 31, 2019 and its condensed consolidating statements of operations and cash flows for the three months ended March 31, 2020 and 2019, for Entsorga West Virginia LLC and the Parent consolidated with other Company subsidiaries not subject to the WVEDA Solid Waste Disposal Revenue Bond restrictions and the elimination entries necessary to present the Company’s financial statements on a consolidated basis. The following condensed consolidating financial information should be read in conjunction with the Company’s consolidated financial statements. Condensed Consolidating Balance Sheet as of March 31, 2020 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Assets Cash $ 1,917,803 $ 17,043 $ — $ 1,934,846 Restricted cash — 1,137,714 — 1,137,714 Other current assets 1,640,754 1,507,533 (123,459) 3,024,828 Current assets 3,558,557 2,662,290 (123,459) 6,097,388 Restricted cash — 2,563,978 — 2,563,978 HEBioT facility and other fixed assets 1,682,271 36,951,832 — 38,634,103 Operating lease right of use assets 24,325 894,260 — 918,585 MBT facility development and license costs 6,278,938 1,764,000 — 8,042,938 Investment in subsidiaries and intercompany accounts 13,069,738 (2,450,776) (10,618,962) — Goodwill — 58,000 — 58,000 Other assets 48,849 — — 48,849 Total assets $ 24,662,678 $ 42,443,584 $ (10,742,421) $ 56,363,841 Liabilities and stockholders’ equity Line of credit $ 1,481,356 $ — $ — $ 1,481,356 Current portion of Debts and Bonds 4,241,578 2,860,000 — 7,101,578 Other current liabilities 3,790,497 5,637,288 — 9,427,785 Current liabilities 9,513,431 8,497,288 — 18,010,719 Notes payable and other debts 962,011 — — 962,011 Accrued interest 1,567,311 — — 1,567,311 Non-current lease liabilities — 916,973 — 916,973 WV EDA bonds — 28,392,733 — 28,392,733 Total liabilities 12,042,753 37,806,994 — 49,849,747 Redeemable preferred stock 726,553 — — 726,553 Stockholder’s equity: Attributable to parent 1,264,636 — — 1,264,636 Attributable to non-controlling interests 10,628,736 4,636,590 (10,742,421) 4,522,905 Stockholders’ equity 11,893,372 4,636,590 (10,742,421) 5,787,541 Total liabilities and stockholders’ equity $ 24,662,678 $ 42,443,584 $ (10,742,421) $ 56,363,841 Condensed Consolidating Statement of Operations for the three months ended March 31, 2020 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 869,209 $ 490,132 $ — $ 1,359,341 Operating expenses HEBioT — 812,427 — 812,427 Rental, service and maintenance expense 260,835 — — 260,835 Equipment 146,404 — — 146,404 Selling, general and administrative 1,668,780 249,643 — 1,918,423 Depreciation and amortization 124,733 490,469 — 615,202 Total operating expenses 2,200,752 1,552,539 — 3,753,291 Loss from operations (1,331,543) (1,062,407) — (2,393,950) Other (income) expenses, net 348,228 651,796 — 1,000,024 Net loss $ (1,679,771) $ (1,714,203) $ — $ (3,393,974) Condensed Consolidating Statement of Cash Flows for the three months ended March 31, 2020 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Cash flows used in operating activities: Net loss $ (1,679,771) $ (1,714,203) $ $ (3,393,974) Non-cash adjustments to reconcile net loss to net cash used in operations 550,567 535,776 1,086,343 Changes in operating assets and liabilities (1,433,781) 1,225,938 (207,843) Net cash used in operations (2,562,985) 47,511 (2,515,474) Cash flow used in investing activities: Purchases of construction in-progress, equipment, fixtures and vehicles (2,649) (18,200) (20,849) Other investing activities (24,509) — (24,509) Net cash used in investing activities (27,158) (18,200) (45,358) Cash flows from financing activities: Issuances of debt and equity 2,695,450 — 2,695,450 Repayments of debt (1,460) — (1,460) Net cash provided by financing activities 2,693,990 — 2,693,990 Effect of exchange rate on cash (33,572) — (33,572) Cash – beginning of period (restricted and unrestricted) 1,847,526 3,689,426 5,536,952 Cash – end of period (restricted and unrestricted) $ 1,917,803 $ 3,718,735 $ $ 5,636,538 Condensed Consolidating Balance Sheet as of December 31, 2019 Parent Entsorga West and other Virginia Subsidiaries LLC Eliminations Consolidated Assets Cash $ 1,847,526 $ — $ — $ 1,847,526 Restricted cash — 1,133,581 — 1,133,581 Other current assets 1,697,910 1,116,821 (64,669) 2,750,062 Current assets 3,545,436 2,250,402 (64,669) 5,731,169 Restricted cash — 2,555,845 — 2,555,845 HEBioT facility and other fixed assets 1,753,730 37,392,601 — 39,146,331 Operating lease right of use assets 48,021 897,026 — 945,047 MBT facility development and license costs 6,254,429 1,795,500 — 8,049,929 Investment in subsidiaries 10,864,783 — (10,864,783) — Goodwill — 58,000 — 58,000 Other assets 53,726 — — 53,726 Total assets $ 22,520,125 $ 44,949,374 $ (10,929,452) $ 56,540,047 Liabilities and stockholders’ equity Line of credit $ 1,479,848 $ — $ — $ 1,479,848 Current portion of WV EDA Bonds — 1,390,000 — 1,390,000 Other current liabilities 2,387,916 6,475,985 (650,894) 8,213,007 Current liabilities 3,867,764 7,865,985 (650,894) 11,082,855 Notes payable and other debts 5,118,125 — — 5,118,125 Accrued interest 1,510,193 — — 1,510,193 Non-current lease liabilities — 915,170 — 915,170 WV EDA bonds — 29,817,426 — 29,817,426 Total liabilities 10,496,082 38,598,581 (650,894) 48,443,769 Redeemable preferred stock 726,553 — — 726,553 Stockholder’s equity: Attributable to parent 2,024,143 — — 2,024,143 Attributable to non-controlling interests 9,273,347 6,350,793 (10,278,558) 5,345,582 Stockholders’ equity 11,297,490 6,350,793 (10,278,558) 7,369,725 Total liabilities and stockholders’ equity $ 22,520,125 $ 44,949,374 $ (10,929,452) $ 56,540,047 Condensed Consolidating Statement of Operations for the three months ended March 31, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 737,701 $ — $ — $ 737,701 Operating expenses Rental, service and maintenance expense 203,203 — — 203,203 Selling, general and administrative 2,057,247 269,115 — 2,326,362 Depreciation and amortization 129,439 — — 129,439 Total operating expenses 2,389,889 269,115 — 2,659,004 Loss from operations (1,652,188) (269,115) — (1,921,303) Other expenses 311,989 27,875 — 339,864 Net loss $ (1,964,177) $ (296,990) $ — $ (2,261,167) Condensed Consolidating Statement of Cash Flows for the three months ended March 31, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Cash flows from operating activities: Net loss $ (1,964,177) $ (296,990) $ — $ (2,261,167) Adjustments to reconcile net loss to net cash used in operations 892,106 31,090 — 923,196 Changes in operating assets and liabilities 63,732 61,590 — 125,322 Net cash used in operations (1,008,339) (204,310) — (1,212,649) Cash flow from investing activities: Construction in process and acquisitions of property and equipment 188 (2,795,012) — (2,794,824) Capital contribution to Entsorga West Virginia, LLC (1,000,000) — 1,000,000 — Other investing activities 52,400 — — 52,400 Net cash used in investing activities (947,412) (2,795,012) 1,000,000 (2,742,424) Cash flows from financing activities: Issuances of debt and equity 900,000 1,000,000 (1,000,000) 900,000 Repayments of debt (2,264) — — (2,264) Deferred financing costs incurred — (43,941) — (43,941) Net cash provided by financing activities 897,736 956,059 (1,000,000) 853,795 Effect of exchange rate on cash 19,851 — — 19,851 Cash – beginning of period (restricted and unrestricted) 2,410,708 6,715,672 — 9,126,380 Cash – end of period (restricted and unrestricted) $ 1,372,544 $ 4,672,409 $ — $ 6,044,953

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Summary of Significant Accounting Policies
Recent Accounting Pronouncements:	Recent Accounting Pronouncements: The Company has not implemented any recent accounting pronouncements during the three months ended March 31, 2020. The Company has not implemented the following accounting standard: In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments . This standard requires an allowance to be recorded for all expected credit losses for certain financial assets. The new standard introduces an approach, based on expected losses, to estimate credit losses on certain types of financial instruments. ASU 2016-13 is effective for public companies for interim and annual period beginning December 15, 2020. Entities are required to apply the standard's provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company has not yet adopted this update and is currently evaluating the effect this new standard will have on its financial condition and results of operations. There have been no other recent accounting pronouncements or changes in accounting pronouncements that have been issued but not yet adopted that are of significance, or potential significance, to the Company.

Equipment on Operating Leases_2

Equipment on Operating Leases, net (Tables)	3 Months Ended
	Mar. 31, 2020
Equipment on Operating Leases, net.
Schedule of equipment on operating leases	Equipment on operating leases consist of the following: March 31, December 31, 2020 2019 Leased equipment $ 3,175,933 $ 3,138,951 Less: accumulated depreciation (1,521,180) (1,413,953) Total Equipment on Operating Leases, net $ 1,654,753 $ 1,724,998
Schedule Of future minimum rental payments receivable for operating leases	The minimum future estimated contractual payments to be received under these leases as of March 31, 2020 is as follows: Year ending December 31, 2020, remaining period $ 1,024,508 2021 990,315 2022 719,049 2023 457,898 2024 and thereafter 181,725 $ 3,373,495

HEBioT facility, equipment, f_2

HEBioT facility, equipment, fixtures and vehicles, net (Tables)	3 Months Ended
	Mar. 31, 2020
HEBioT facility, equipment, fixtures and vehicles, net
Schedule of HEBioT facility, equipment, fixtures and vehicles	HEBioT facility, equipment, fixtures and vehicles, net consist of the following: March 31, December 31, 2020 2019 HEBioT facility $ 31,142,974 $ 31,142,974 HEBioT equipment 7,407,096 7,388,896 Computer software and hardware 115,076 112,629 Furniture and fixtures 48,196 48,196 Vehicles 50,319 50,319 38,763,661 38,743,014 Less: accumulated depreciation and amortization (1,784,311) (1,321,681) Total HEBioT facility, equipment, fixtures and vehicles, net $ 36,979,350 $ 37,421,333

MBT Facility Development and _2

MBT Facility Development and License Costs (Tables)	3 Months Ended
	Mar. 31, 2020
MBT Facility Development and License Costs
Schedule of MBT facility development and license costs	MBT Facility Development and License Costs consist of the following: March 31, December 31, 2020 2019 MBT Projects Survey and engineering 259,738 235,229 Technology Licenses Future site 6,019,200 6,019,200 Martinsburg, West Virginia, net of $126,000 and $94,500 of amortization as of March 31, 2020 and December 31, 2019 1,764,000 1,795,500 Total Technology Licenses 7,783,200 7,814,700 Total MBT Facility Development and License Costs $ 8,042,938 $ 8,049,929

Line of Credit, Promissory No_2

Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts (Tables)	3 Months Ended
	Mar. 31, 2020
Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts
Schedule of long-term debt	Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts consist of the following: March 31, 2020 December 31, 2019 Related Related Total Party Total Party Line of credit $ 1,481,356 $ — $ 1,479,848 $ — Senior secured promissory note 4,241,578 — 4,160,490 — Junior promissory note 954,885 954,885 949,434 949,434 Note payable 100,000 — 100,000 — Advances from related parties (See Note 14 Related Parties) 1,410,000 1,410,000 210,000 210,000 Long term debt - current and long-term portion 11,345 — 12,806 —
Schedule of maturities of long-term debts	Contractual Maturities of Senior Secured, Junior Promissory, Notes Payable and Long Term Debt — As of March 31, 2020, excluding discounts and deferred finance costs, which are being amortized as interest expense, are as follow: Non- Year Ending December 31, Amortizing Amortizing Total 2020 (Remaining) $ 3,144 $ 100,000 $ 103,144 2021 4,380 1,875,000 1,879,380 2022 3,821 2,500,000 2,503,821 2023 — 625,000 625,000 2024 and thereafter — 1,044,477 1,044,477 Total $ 11,345 $ 6,144,477 $ 6,155,822

Entsorga West Virginia, LLC W_2

Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds (Tables)	3 Months Ended
	Mar. 31, 2020
Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds
Schedule of future sinking fund payments by the borrower	The future sinking fund payments by the Borrower as of March 31, 2020 are as follow: 2016 Issue 2016 Issue 2018 Issue Year Ending December 31, 2026 Series 2036 Series 2036 Series Total 2020 (remaining) $ 1,160,000 $ — $ 230,000 $ 1,390,000 2021 1,215,000 — 255,000 1,470,000 2022 900,000 — 275,000 1,175,000 2023 965,000 — 300,000 1,265,000 2024 and thereafter 3,295,000 17,465,000 6,940,000 27,700,000 Total $ 7,535,000 $ 17,465,000 $ 8,000,000 $ 33,000,000

Equity and Equity Transactions

Equity and Equity Transactions (Tables)	3 Months Ended
	Mar. 31, 2020
Equity and Equity Transactions
Schedule of preferred units	As of March 31, 2020 and December 31, 2018, 17,417,288 and 17,300,899 shares of common stock have been issued; and 3,209,210 and 3,179,120 shares, respectively, of preferred stock have been designated in five series of shares, which have a total of $1,192,619 in accumulated, but undeclared preferential dividends as of March 31, 2020, as follows: Designated Par Stated Shares Outstanding Designation Shares Value Value March 31, 2020 December 31, 2019 Series A Convertible Preferred Stock 333,401 $ 0.0001 $ 5.00 145,312 145,312 Series B Convertible Preferred Stock 1,111,200 0.0001 $ 5.00 — — Series C Convertible Preferred Stock 1,000,000 0.0001 $ 10.00 427,500 427,500 Series D Convertible Preferred Stock 20,000 0.0001 $ 100.00 18,850 18,850 Series E Convertible Preferred Stock 714,519 0.0001 $ 2.64 264,519 264,519 Series F Convertible Preferred Stock 30,090 0.0001 $ 115.00 13,045 —
Schedule of share-based compensation, activity	the Company has the 4,852,858 warrants to acquire the Company’s common stock outstanding as of March 31, 2020, as follows: Weighted Expiring During the Year Exercise Price Average Exercises Ending December 31, Warrant Shares per Share Price per Share 2020 22,860 $3.50 $3.50 2021 1,768,516 $1.80 to $3.75 $3.25 2022 1,699,861 $1.80 to $5.00 $2.60 2023 740,749 $1.80 $1.80 2024 385,945 $1.80 $1.80 2025 234,927 $2.25 to $2.30 $2.29
Schedule of warrants or rights outstanding	The following table summarizes the outstanding warrant activity for the three months ended March 31, 2020: Outstanding, January 1, 2020 4,674,261 Issued as a result of Series F Convertible Preferred Stock offering 178,597 Exercised — Expired — Outstanding, March 31, 2020 4,852,858

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	3 Months Ended
	Mar. 31, 2020
Equity Incentive Plans
Schedule of compensation expenses related to stock options and restricted stock	Compensation expense related to stock options and restricted stock for the three months ended March 31, was: 2020 2019 Stock options $ 48,460 $ 58,388 Restricted stock 231,745 239,361 Total $ 280,205 $ 297,749 Compensation expense related to stock options and restricted stock for the three months ended March 31, are reflected in the following captions within operating expenses in the condensed consolidated statements of operations and comprehensive loss: 2020 2019 Rental, service and maintenance $ 3,317 $ 5,755 Selling, general and administrative 276,888 291,994 Total $ 280,205 $ 297,749
Schedule of restricted stock	The following summarizes the Company’s stock option activity for the three months ended March 31, 2020: Weighted Average Weighted Remaining Average Contractual Number of Exercise Life Aggregate Options Price (in Years) Intrinsic Value Outstanding – January 1, 2020 363,826 $ 3.71 7.34 — Granted 155,450 — — Exercised — — — — Forfeited, Canceled or Expired — — — — Outstanding – March 31, 2020 519,276 $ 3.20 7.91 — Exercisable – March 31, 2020 241,651 $ 3.67 6.59 — The following summarizes the Company’s restricted stock unit activity for the three months ended March 31, 2020: Balance, January 1, 2020 291,730 Grants 269,060 Forfeited — Vested — Balance, March 31, 2020 560,790

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Mar. 31, 2020
Revenue
Schedule of disaggregation of revenue	Disaggregation of Revenue — The disaggregation of revenue for the three months ended March 31, is as follows: 2020 2019 Revenue Type: Rental of digesters $ 386,254 $ 341,665 Services 601,433 372,975 Product sales 371,654 23,061 Total Revenue $ 1,359,341 $ 737,701

Risk Concentrations (Tables)

Risk Concentrations (Tables)	3 Months Ended
	Mar. 31, 2020
Risk Concentrations
Schedule of revenue from external customers by geographic areas	The Company operates as a single segment on a worldwide basis through its subsidiaries, resellers and independent sales agents. Gross revenues and net non-current tangible assets on a domestic and international basis are as follows: United States International Total 2020: Revenue, for the three months ended March 31, 2020 $ 1,225,910 $ 133,431 $ 1,359,341 Non-current tangible assets, as of March 31, 2020 38,330,741 316,862 38,647,603 2019: Revenue, for the three months ended March 31, 2019 $ 641,646 $ 96,055 $ 737,701 Non-current tangible assets, as of December 31, 2019 38,803,333 355,825 39,159,658

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2020
Leases
Schedule of maturities of lease liabilities	Maturities of lease liabilities under these leases, which have a weighted average remaining term of 25.6 years, as of March 31, 2020 is: Year Ending December 31, 2020 (remaining) $ 95,521 2021 109,000 2022 113,000 2023 113,000 2024 and thereafter 2,980,750 Total lease payments 3,411,271 Less imputed interest (2,372,788) Present value of lease liabilities $ 1,038,483

Related Party Transactions (Tab

Related Party Transactions (Tables)	3 Months Ended
	Mar. 31, 2020
Related Party Transactions
Schedule of related party transactions	The table below presents the face amount of direct related party assets and liabilities and other transactions or conditions as of or during the periods indicated. March 31, December 31, 2020 2019 Assets: Accounts receivable (a) (b) $ 1,860,171 $ 1,370,867 Intangible assets, net, included in other assets (c) 35,349 40,399 Liabilities: Accounts payable (c) (d) (e) (f) 2,654,592 2,531,034 Accrued interest payable 101,907 46,796 Long term accrued interest (g) 1,567,311 1,510,193 Advance from related party (h) 1,410,000 210,000 Junior promissory note (g) 954,885 949,434 Other: Line of credit guarantee (i) 1,481,356 1,479,848 The table below presents direct related party expenses or transactions for the three months ended March 31, 2020 and 2019. Compensation and related costs for employees of the Company are excluded from the table below. 2020 2019 Management advisory and other fees (a) $ 75,000 $ 250,000 HEBioT revenue (b) 406,958 — Operating expenses - HEBioT (d) 298,803 — Operating expenses - Selling, general and administrative (e) 25,156 24,537 Operating expenses - Selling, general and administrative (c) (f) 110,650 18,750 Interest expense 97,948 63,628 Debt guarantee fees (i) 16,875 16,875 Summary notes: a - Management Advisory Fees f - Business Services Fees b - HEBioT Disposal Revenues g - Junior Promissory Note c - Distribution Agreement h - Advances from Related Parties d - Disposal costs i - Line of Credit e - Facility Lease

Supplemental Consolidated Sta_2

Supplemental Consolidated Statement of Cash Flows Information (Tables)	3 Months Ended
	Mar. 31, 2020
Supplemental Consolidated Statement of Cash Flows Information
Schedule of supplemental cash flow	Changes in non-cash operating assets and liabilities, as well as other supplemental cash flow disclosures for the three months ended March 31, are as follows. 2020 2019 Changes in operating assets and liabilities: Accounts receivable $ (324,890) $ 48,266 Inventory 31,981 76,930 Prepaid expenses and other assets (25,989) (36,508) Accounts payable 672,061 3,088,732 Accrued interest payable (525,392) (399,764) Accrued expenses (9,591) (2,668,827) Deferred revenue 11,977 12,142 Customer deposits (38,000) 4,351 Net change in operating assets and liabilities $ (207,843) $ 125,322 Supplementary cash flow information: Cash paid during the periods for: Interest $ 1,387,402 $ 1,082,526 Income taxes — — Supplementary Disclosure of Non-Cash Investing and Financing Activities: Transfer of inventory to leased equipment $ 67,604 $ 6,884 Accrual of Series A preferred stock dividends 17,564 18,372 Payment of Series A preferred stock dividends in common stock 25,000 — Reconciliation of Cash and Restricted Cash: Cash $ 1,934,846 $ 1,374,564 Restricted cash (current) 1,137,714 2,137,456 Restricted cash (non-current) 2,563,978 2,532,933 Total cash and restricted cash at the end of the period $ 5,636,538 $ 6,044,953

Condensed Consolidating Finan_2

Condensed Consolidating Financial Information (Tables)	3 Months Ended
	Mar. 31, 2020
Condensed Consolidating Financial Information
Schedule of condensed financial statements	Condensed Consolidating Balance Sheet as of March 31, 2020 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Assets Cash $ 1,917,803 $ 17,043 $ — $ 1,934,846 Restricted cash — 1,137,714 — 1,137,714 Other current assets 1,640,754 1,507,533 (123,459) 3,024,828 Current assets 3,558,557 2,662,290 (123,459) 6,097,388 Restricted cash — 2,563,978 — 2,563,978 HEBioT facility and other fixed assets 1,682,271 36,951,832 — 38,634,103 Operating lease right of use assets 24,325 894,260 — 918,585 MBT facility development and license costs 6,278,938 1,764,000 — 8,042,938 Investment in subsidiaries and intercompany accounts 13,069,738 (2,450,776) (10,618,962) — Goodwill — 58,000 — 58,000 Other assets 48,849 — — 48,849 Total assets $ 24,662,678 $ 42,443,584 $ (10,742,421) $ 56,363,841 Liabilities and stockholders’ equity Line of credit $ 1,481,356 $ — $ — $ 1,481,356 Current portion of Debts and Bonds 4,241,578 2,860,000 — 7,101,578 Other current liabilities 3,790,497 5,637,288 — 9,427,785 Current liabilities 9,513,431 8,497,288 — 18,010,719 Notes payable and other debts 962,011 — — 962,011 Accrued interest 1,567,311 — — 1,567,311 Non-current lease liabilities — 916,973 — 916,973 WV EDA bonds — 28,392,733 — 28,392,733 Total liabilities 12,042,753 37,806,994 — 49,849,747 Redeemable preferred stock 726,553 — — 726,553 Stockholder’s equity: Attributable to parent 1,264,636 — — 1,264,636 Attributable to non-controlling interests 10,628,736 4,636,590 (10,742,421) 4,522,905 Stockholders’ equity 11,893,372 4,636,590 (10,742,421) 5,787,541 Total liabilities and stockholders’ equity $ 24,662,678 $ 42,443,584 $ (10,742,421) $ 56,363,841 Condensed Consolidating Balance Sheet as of December 31, 2019 Parent Entsorga West and other Virginia Subsidiaries LLC Eliminations Consolidated Assets Cash $ 1,847,526 $ — $ — $ 1,847,526 Restricted cash — 1,133,581 — 1,133,581 Other current assets 1,697,910 1,116,821 (64,669) 2,750,062 Current assets 3,545,436 2,250,402 (64,669) 5,731,169 Restricted cash — 2,555,845 — 2,555,845 HEBioT facility and other fixed assets 1,753,730 37,392,601 — 39,146,331 Operating lease right of use assets 48,021 897,026 — 945,047 MBT facility development and license costs 6,254,429 1,795,500 — 8,049,929 Investment in subsidiaries 10,864,783 — (10,864,783) — Goodwill — 58,000 — 58,000 Other assets 53,726 — — 53,726 Total assets $ 22,520,125 $ 44,949,374 $ (10,929,452) $ 56,540,047 Liabilities and stockholders’ equity Line of credit $ 1,479,848 $ — $ — $ 1,479,848 Current portion of WV EDA Bonds — 1,390,000 — 1,390,000 Other current liabilities 2,387,916 6,475,985 (650,894) 8,213,007 Current liabilities 3,867,764 7,865,985 (650,894) 11,082,855 Notes payable and other debts 5,118,125 — — 5,118,125 Accrued interest 1,510,193 — — 1,510,193 Non-current lease liabilities — 915,170 — 915,170 WV EDA bonds — 29,817,426 — 29,817,426 Total liabilities 10,496,082 38,598,581 (650,894) 48,443,769 Redeemable preferred stock 726,553 — — 726,553 Stockholder’s equity: Attributable to parent 2,024,143 — — 2,024,143 Attributable to non-controlling interests 9,273,347 6,350,793 (10,278,558) 5,345,582 Stockholders’ equity 11,297,490 6,350,793 (10,278,558) 7,369,725 Total liabilities and stockholders’ equity $ 22,520,125 $ 44,949,374 $ (10,929,452) $ 56,540,047
Schedule of condensed income statement	Condensed Consolidating Statement of Operations for the three months ended March 31, 2020 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 869,209 $ 490,132 $ — $ 1,359,341 Operating expenses HEBioT — 812,427 — 812,427 Rental, service and maintenance expense 260,835 — — 260,835 Equipment 146,404 — — 146,404 Selling, general and administrative 1,668,780 249,643 — 1,918,423 Depreciation and amortization 124,733 490,469 — 615,202 Total operating expenses 2,200,752 1,552,539 — 3,753,291 Loss from operations (1,331,543) (1,062,407) — (2,393,950) Other (income) expenses, net 348,228 651,796 — 1,000,024 Net loss $ (1,679,771) $ (1,714,203) $ — $ (3,393,974) Condensed Consolidating Statement of Operations for the three months ended March 31, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 737,701 $ — $ — $ 737,701 Operating expenses Rental, service and maintenance expense 203,203 — — 203,203 Selling, general and administrative 2,057,247 269,115 — 2,326,362 Depreciation and amortization 129,439 — — 129,439 Total operating expenses 2,389,889 269,115 — 2,659,004 Loss from operations (1,652,188) (269,115) — (1,921,303) Other expenses 311,989 27,875 — 339,864 Net loss $ (1,964,177) $ (296,990) $ — $ (2,261,167)
Schedule of condensed cash flow Statement	Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Cash flows used in operating activities: Net loss $ (1,679,771) $ (1,714,203) $ $ (3,393,974) Non-cash adjustments to reconcile net loss to net cash used in operations 550,567 535,776 1,086,343 Changes in operating assets and liabilities (1,433,781) 1,225,938 (207,843) Net cash used in operations (2,562,985) 47,511 (2,515,474) Cash flow used in investing activities: Purchases of construction in-progress, equipment, fixtures and vehicles (2,649) (18,200) (20,849) Other investing activities (24,509) — (24,509) Net cash used in investing activities (27,158) (18,200) (45,358) Cash flows from financing activities: Issuances of debt and equity 2,695,450 — 2,695,450 Repayments of debt (1,460) — (1,460) Net cash provided by financing activities 2,693,990 — 2,693,990 Effect of exchange rate on cash (33,572) — (33,572) Cash – beginning of period (restricted and unrestricted) 1,847,526 3,689,426 5,536,952 Cash – end of period (restricted and unrestricted) $ 1,917,803 $ 3,718,735 $ $ 5,636,538 Condensed Consolidating Statement of Cash Flows for the three months ended March 31, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Cash flows from operating activities: Net loss $ (1,964,177) $ (296,990) $ — $ (2,261,167) Adjustments to reconcile net loss to net cash used in operations 892,106 31,090 — 923,196 Changes in operating assets and liabilities 63,732 61,590 — 125,322 Net cash used in operations (1,008,339) (204,310) — (1,212,649) Cash flow from investing activities: Construction in process and acquisitions of property and equipment 188 (2,795,012) — (2,794,824) Capital contribution to Entsorga West Virginia, LLC (1,000,000) — 1,000,000 — Other investing activities 52,400 — — 52,400 Net cash used in investing activities (947,412) (2,795,012) 1,000,000 (2,742,424) Cash flows from financing activities: Issuances of debt and equity 900,000 1,000,000 (1,000,000) 900,000 Repayments of debt (2,264) — — (2,264) Deferred financing costs incurred — (43,941) — (43,941) Net cash provided by financing activities 897,736 956,059 (1,000,000) 853,795 Effect of exchange rate on cash 19,851 — — 19,851 Cash – beginning of period (restricted and unrestricted) 2,410,708 6,715,672 — 9,126,380 Cash – end of period (restricted and unrestricted) $ 1,372,544 $ 4,672,409 $ — $ 6,044,953

Basis of Presentation and Goi_2

Basis of Presentation and Going Concern (Details) - USD ($)	May 13, 2020	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2018
Basis Of Presentation And Going Concern [Line Items]
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		$ 3,393,974	$ 2,261,167
Operating Income (Loss)		2,393,950	1,921,303
Net Cash Provided by (Used in) Operating Activities		(2,515,474)	(1,212,649)
Working Capital Deficit		11,913,331
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		5,787,541		$ 7,369,725
Stockholders' Equity Attributable to Parent		1,264,636	2,486,715	$ 2,024,143	$ 3,405,551
Proceeds from common stock issuance, net of offering costs		3,035,557
Proceeds from Issuance of Convertible Preferred Stock		1,495,450	$ 750,000
Senior Notes, Current		$ 4,241,578
Refuel America LLC [Member]
Basis Of Presentation And Going Concern [Line Items]
Equity Method Investment, Ownership Percentage		60.00%
Entsorgia West Virginia LLC [Member]
Basis Of Presentation And Going Concern [Line Items]
Equity Method Investment, Ownership Percentage		88.70%	78.20%	88.70%
Subsequent events
Basis Of Presentation And Going Concern [Line Items]
Application amount approved and funded under paycheck protection program	$ 421,300

Equipment on Operating Leases_3

Equipment on Operating Leases, net (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Less: accumulated depreciation	$ (1,784,311)	$ (1,321,681)
Total Equipment on Operating Leases, net	1,654,753	1,724,998
Assets Held under Operating Leases [Member]
Leased equipment	3,175,933	3,138,951
Less: accumulated depreciation	(1,521,180)	(1,413,953)
Total Equipment on Operating Leases, net	$ 1,654,753	$ 1,724,998

Equipment on Operating Leases_4

Equipment on Operating Leases, net - Minimum Future Estimated Contractual Payments to be Received (Details)	Mar. 31, 2020USD ($)
Equipment on Operating Leases, net.
2020, remaining period	$ 1,024,508
2021	990,315
2022	719,049
2023	457,898
2024 and thereafter	181,725
Total minimum lease income	$ 3,373,495

Equipment on Operating Leases_5

Equipment on Operating Leases, net - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Leases
Operating Leases, Income Statement, Lease Revenue, Total	$ 386,254	$ 341,665
Depreciation	$ 115,866	$ 101,502

HEBioT facility, equipment, f_3

HEBioT facility, equipment, fixtures and vehicles, net (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Plant and Equipment, Gross	$ 38,763,661	$ 38,743,014
Less: accumulated depreciation and amortization	(1,784,311)	(1,321,681)
Total HEBioT facility, equipment, fixtures and vehicles, net	36,979,350	37,421,333
HEBioT facility
Property, Plant and Equipment [Line Items]
Plant and Equipment, Gross	31,142,974	31,142,974
HEBiot equipment
Property, Plant and Equipment [Line Items]
Plant and Equipment, Gross	7,407,096	7,388,896
Computer Software And Hardware [Member]
Property, Plant and Equipment [Line Items]
Plant and Equipment, Gross	115,076	112,629
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Plant and Equipment, Gross	48,196	48,196
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Plant and Equipment, Gross	$ 50,319	$ 50,319

MBT Facility Development and _3

MBT Facility Development and License Costs (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Land and Land Improvements	$ 8,042,938	$ 8,049,929
Survey and Engineering Costs [Member]
Land and Land Improvements	259,738	235,229
Technology Licenses Cost [Member]
Land and Land Improvements	7,783,200	7,814,700
Technology Licenses Cost [Member] | Future Site [Member]
Land and Land Improvements	6,019,200	6,019,200
Technology Licenses Cost [Member] | Martinsburg West Virginia [Member]
Land and Land Improvements	$ 1,764,000	$ 1,795,500

MBT Facility Development and _4

MBT Facility Development and License Costs - Additional Information (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2018
Royalty Guarantees, Commitments, Amount	$ 6,019,200
Intellectual Property [Member]
Finite-lived Intangible Assets Acquired	31,500			$ 1,890,000
Amortization Expenses		$ 0
Martinsburg West Virginia [Member] | Intellectual Property [Member]
Amortization Expenses	$ 126,000		$ 94,500

Line of Credit, Promissory No_3

Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Line of credit	$ 1,481,356	$ 1,479,848
Senior secured promissory note	4,241,578	4,160,490
Junior promissory note	954,885	949,434
Notes payable	100,000	100,000
Advances from related parties	1,410,000	210,000
Long term debt - current and long-term portion	11,345	12,806
Related Party [Member]
Debt Instrument [Line Items]
Line of credit	0	0
Senior secured promissory note	0	0
Junior promissory note	954,885	949,434
Notes payable	0	0
Advances from related parties	1,410,000	210,000
Long term debt - current and long-term portion	$ 0	$ 0

Line of Credit, Promissory No_4

Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts - Contractual maturities of Long Term Debts (Details)	Mar. 31, 2020USD ($)
2020 (Remaining)	$ 103,144
2021	1,879,380
2022	2,503,821
2023	625,000
2024 and thereafter	1,044,477
Total	6,155,822
Amortizing [Member]
2020 (Remaining)	3,144
2021	4,380
2022	3,821
2023	0
2024 and thereafter	0
Total	11,345
Non-Amortizing [Member]
2020 (Remaining)	100,000
2021	1,875,000
2022	2,500,000
2023	625,000
2024 and thereafter	1,044,477
Total	$ 6,144,477

Line of Credit, Promissory No_5

Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Effective interest rate	5.00%
Senior secured promissory note	$ 4,241,578	$ 4,160,490
Line of credit carrying value as of the balance sheet	$ 1,481,356	$ 1,479,848
Preferred Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Junior promissory note	$ 954,885	$ 949,434
Current portion of Debts and Bonds	$ 2,860,000	$ 1,390,000
Comerica Line of Credit [Member]
Effective interest rate	5.58%	5.71%
Variable Interest rate on the debt instrument	3.00%
Miichaelson Senior Secured Term Promissory [Member]
Debt Instruments of face values issue	$ 5,000,000
Interest rate of stated percentage	10.25%
Maturity date of debt instruments	Feb. 2, 2023
Principal installments payment	$ 625,000
Unsecured Debt [Member]
Debt Instruments of face values issue	$ 100,000	$ 100,000
Interest rate of stated percentage	10.00%	10.00%

Entsorga West Virginia, LLC W_3

Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds (Details)	3 Months Ended
	Mar. 31, 2020USD ($)
Debt Instrument, Sinking Fund Payment	$ 33,000,000
Debt Instrument, Redemption, Period One [Member]
Debt Instrument, Sinking Fund Payment	1,390,000
Debt Instrument, Redemption, Period Two [Member]
Debt Instrument, Sinking Fund Payment	1,470,000
Debt Instrument, Redemption, Period Three [Member]
Debt Instrument, Sinking Fund Payment	1,175,000
Debt Instrument, Redemption, Period Four [Member]
Debt Instrument, Sinking Fund Payment	1,265,000
Debt Instrument, Redemption, Period Five [Member]
Debt Instrument, Sinking Fund Payment	27,700,000
2016 Issue 2026 Series [Member]
Debt Instrument, Sinking Fund Payment	7,535,000
2016 Issue 2026 Series [Member] | Debt Instrument, Redemption, Period One [Member]
Debt Instrument, Sinking Fund Payment	1,160,000
2016 Issue 2026 Series [Member] | Debt Instrument, Redemption, Period Two [Member]
Debt Instrument, Sinking Fund Payment	1,215,000
2016 Issue 2026 Series [Member] | Debt Instrument, Redemption, Period Three [Member]
Debt Instrument, Sinking Fund Payment	900,000
2016 Issue 2026 Series [Member] | Debt Instrument, Redemption, Period Four [Member]
Debt Instrument, Sinking Fund Payment	965,000
2016 Issue 2026 Series [Member] | Debt Instrument, Redemption, Period Five [Member]
Debt Instrument, Sinking Fund Payment	3,295,000
2016 Issue 2036 Series [Member]
Debt Instrument, Sinking Fund Payment	17,465,000
2016 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period One [Member]
Debt Instrument, Sinking Fund Payment	0
2016 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Two [Member]
Debt Instrument, Sinking Fund Payment	0
2016 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Three [Member]
Debt Instrument, Sinking Fund Payment	0
2016 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Four [Member]
Debt Instrument, Sinking Fund Payment	0
2016 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Five [Member]
Debt Instrument, Sinking Fund Payment	17,465,000
2018 Issue 2036 Series [Member]
Debt Instrument, Sinking Fund Payment	8,000,000
2018 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period One [Member]
Debt Instrument, Sinking Fund Payment	230,000
2018 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Two [Member]
Debt Instrument, Sinking Fund Payment	255,000
2018 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Three [Member]
Debt Instrument, Sinking Fund Payment	275,000
2018 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Four [Member]
Debt Instrument, Sinking Fund Payment	300,000
2018 Issue 2036 Series [Member] | Debt Instrument, Redemption, Period Five [Member]
Debt Instrument, Sinking Fund Payment	$ 6,940,000

Entsorga West Virginia, LLC W_4

Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds - Additional Information (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2016	Nov. 01, 2018
Financial Standby Letter of Credit [Member]
Collateral Amount					$ 1,250,000
WVEDA Bonds [Member]
Debt Instruments of face values issue	$ 33,000,000	$ 33,000,000		$ 25,000,000
Unamortized Debt Issuance Expense	2,207,759	2,207,759
Amortization of Debt Issuance Costs	$ 460,492	$ 415,185
Series One [Member] | WVEDA Bonds [Member]
Debt Instruments of face values issue				$ 7,535,000
Interest rate of stated percentage				6.75%
Maturity date of debt instruments				Feb. 1, 2026
Series Two [Member] | WVEDA Bonds [Member]
Debt Instruments of face values issue				$ 17,465,000
Interest rate of stated percentage				7.25%
Maturity date of debt instruments				Feb. 1, 2036
Series Three [Member] | WVEDA Bonds [Member]
Debt Instruments of face values issue			$ 8,000,000
Interest rate of stated percentage			8.75%
Maturity date of debt instruments			Feb. 1, 2036

Equity and Equity Transaction_2

Equity and Equity Transactions (Details) - $ / shares	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Preferred Stock, Authorized Shares	3,209,210	3,179,120	3,179,120
Preferred Stock, Shares Outstanding	869,226	856,181
Series A Convertible Preferred Stock [Member]
Preferred Stock, Authorized Shares	333,401
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 5
Preferred Stock, Shares Outstanding	145,312	145,312
Series B Convertible Preferred Stock [Member]
Preferred Stock, Authorized Shares	1,111,200
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 5
Preferred Stock, Shares Outstanding	0	0
Series C Convertible Preferred Stock [Member]
Preferred Stock, Authorized Shares	1,000,000	1,000,000
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 10
Preferred Stock, Shares Outstanding	427,500	427,500
Series D Convertible Preferred Stock [Member]
Preferred Stock, Authorized Shares	20,000	20,000
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 100
Preferred Stock, Shares Outstanding	18,850	18,850
Series E Convertible Preferred Stock [Member]
Preferred Stock, Authorized Shares	714,519	714,519
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 2.64
Preferred Stock, Shares Outstanding	264,519	264,519
Series F Convertible Preferred Stock [Member]
Preferred Stock, Authorized Shares	30,090	30,090
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 115
Preferred Stock, Shares Outstanding	13,045	0

Equity and Equity Transaction_3

Equity and Equity Transactions - Warrants (Details) - $ / shares	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019
Class of Warrant or Right, Outstanding	4,852,858	4,674,261
2020
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 3.50
Class of Warrant or Right, Outstanding	22,860
Weighted Average Price per Share	$ 3.50
2021
Class of Warrant or Right, Outstanding	1,768,516
Weighted Average Price per Share	$ 3.25
2022
Class of Warrant or Right, Outstanding	1,699,861
Weighted Average Price per Share	$ 2.60
2023
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.80
Class of Warrant or Right, Outstanding	740,749
Weighted Average Price per Share	$ 1.80
2024
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.80
Class of Warrant or Right, Outstanding	385,945
Weighted Average Price per Share	$ 1.80
2025
Class of Warrant or Right, Outstanding			234,927
Weighted Average Price per Share	2.29
Maximum [Member] | 2021
Class of Warrant or Right, Exercise Price of Warrants or Rights	3.75
Maximum [Member] | 2022
Class of Warrant or Right, Exercise Price of Warrants or Rights	5
Maximum [Member] | 2025
Class of Warrant or Right, Exercise Price of Warrants or Rights	2.30
Minimum [Member] | 2021
Class of Warrant or Right, Exercise Price of Warrants or Rights	1.80
Minimum [Member] | 2022
Class of Warrant or Right, Exercise Price of Warrants or Rights	1.80
Minimum [Member] | 2025
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 2.25

Equity and Equity Transaction_4

Equity and Equity Transactions - Outstanding Warrant Activity (Details)	3 Months Ended
	Mar. 31, 2020shares
Outstanding Beginning Balance	4,674,261
Exercised	0
Expired	0
Outstanding Ending Balance	4,852,858
Series F Convertible Preferred Stock [Member]
Issued as a result of Series F Convertible Preferred Stock offering	178,597

Equity and Equity Transaction_5

Equity and Equity Transactions - Additional Information (Details) - USD ($)	Mar. 18, 2020	Mar. 09, 2020	Mar. 31, 2020	Apr. 06, 2020	Dec. 31, 2019	Dec. 31, 2018
Common Stock, Shares Authorized			50,000,000		50,000,000	50,000,000
Common stock, par value			$ 0.0001		$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized			10,000,000		10,000,000	10,000,000
Common Stock, Shares, Issued			17,417,288		17,300,899	17,300,899
Preferred stock, Designated shares			3,209,210		3,179,120	3,179,120
Dividends Payable			$ 1,192,619
Description of Equity Method Investment Ownership Percentage			The consolidated financial statements include less than 100% owned and controlled subsidiaries
Equity Method Investment, Description of Principal Activities			include equity attributable to non-controlling interests that take the form of the underlying legal structures of the less than 100% owned subsidiaries
Preferred Stock Initial Closing Cost	$ 1,500,000
Preferred Stock New Series Shares	13,045
Common Stock Warrants	178,597			7,750
Warrant valuations	$ 50,836
Issuance cost	$ 4,550
Net proceeds of the offering			$ 3,035,557
Preferred Stock, Value, Issued
Preferred stock, stated value			$ 726,553		$ 726,553
Preferred Stock, Par or Stated Value Per Share			$ 0.0001		$ 0.0001
Class of Warrant or Right, Outstanding			4,852,858		4,674,261
Class of Warrant or Right			4,852,858		4,674,261
Preferred Stock, Shares Outstanding			869,226		856,181
Common Stock [Member]
Common Stock issued for accrued dividends (in shares)			13,889
Series D Convertible Preferred Stock [Member]
Preferred stock, Designated shares			20,000		20,000
Par Value Per Share (in dollars per share)			$ 0.0001
Stated Value Per Share (in dollars per share)			$ 100
Preferred Stock, Value, Issued			$ 1,505,262		$ 1,505,262
Preferred Stock, Shares Outstanding			18,850		18,850
Series C Convertible Preferred Stock [Member]
Preferred stock, Designated shares			1,000,000		1,000,000
Par Value Per Share (in dollars per share)			$ 0.0001
Stated Value Per Share (in dollars per share)			$ 10
Preferred Stock, Value, Issued			$ 3,050,142		$ 3,050,142
Preferred Stock, Shares Outstanding			427,500		427,500
Series F Redeemable, Convertible Preferred Stock [Member]
Common stock, par value		$ 2.30
Preferred stock, Designated shares		30,090
Preferred Stock Initial Closing Cost				$ 65,000
Preferred Stock New Series Shares				566
Par Value Per Share (in dollars per share)		$ 0.0001
Stated Value Per Share (in dollars per share)		$ 115
Conversion price (in dollars per share)		2.10%
Period after which the preferred stock can be redeemed		24 months
Trading share price		3.00%
Daily trading volume (in shares)		50,000
Warrants Expiration Period		5 years
Warrants issued		178,597
Preferred Stock, Dividend Rate, Percentage		9.00%

Equity Incentive Plans - Compen

Equity Incentive Plans - Compensation Expenses Related to Stock Options (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Stock options	$ 48,460	$ 58,388
Restricted stock	231,745	239,361
Total	280,205	297,749
Rental Service And Maintenance [Member]
Total	3,317	5,755
Selling, General and Administrative Expenses [Member]
Total	$ 276,888	$ 291,994

Equity Incentive Plans - Stock

Equity Incentive Plans - Stock option activity (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Equity Incentive Plans
Number of options, Beginning Balance	363,826
Number of Options, Granted or vested	155,450
Number of Options, Ending Balance	519,276	363,826
Number of Options, Exercisable, Ending Balance	241,651
Weighted Average Exercise Price, Beginning Balance	$ 3.71
Weighted Average Exercise Price, Granted or vested	2
Weighted Average Exercise Price, Ending Balance	$ 3.20	$ 3.71
Weighted Average Remaining Contractual Life (in Years), Outstanding	7 years 10 months 28 days	7 years 4 months 2 days
Weighted Average Remaining Contractual Life (in Years), Exercisable	6 years 7 months 2 days
Weighted Average Exercise Price, Exercisable	$ 3.67

Equity Incentive Plans - Schedu

Equity Incentive Plans - Schedule of Restricted Stock (Details)	3 Months Ended
	Mar. 31, 2020shares
Equity Incentive Plans
Unvested balance at beginning	291,730
Grants	269,060
Forfeited or Canceled	0
Vested	0
Unvested balance at end	560,790

Equity Incentive Plans - Additi

Equity Incentive Plans - Additional Information (Details) - USD ($)	Jan. 30, 2020	Mar. 31, 2020	Dec. 31, 2017	Dec. 31, 2015
Restricted Stock Units		269,060
Equity Incentive Plan 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized				750,000
Executive Incentive Plan 2017 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			1,000,000
Nonqualified Options	155,450
Restricted Stock Units	269,060
Fair value options, Granted	$ 162,959
Risk-free Interest Rate	1.44%
Expected dividend yield	0.00%
Expected volatility	49.24%
Weighted average vesting period	9 months
Restricted Stock Value	$ 538,120
Executive Incentive Plan 2017 [Member] | Minimum [Member]
Expected term in years	1 year
Executive Incentive Plan 2017 [Member] | Maximum [Member]
Expected term in years	2 years 11 months 1 day

Revenue (Details)

Revenue (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Disaggregation of Revenue [Line Items]
Total Revenue	$ 1,359,341	$ 737,701
Rental of digesters
Disaggregation of Revenue [Line Items]
Total Revenue	386,254	341,665
Services
Disaggregation of Revenue [Line Items]
Total Revenue	601,433	372,975
Product sales
Disaggregation of Revenue [Line Items]
Total Revenue	$ 371,654	$ 23,061

Risk Concentrations (Details)

Risk Concentrations (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Concentration Risk [Line Items]
Revenue	$ 1,359,341	$ 737,701
Non-current tangible assets	38,647,603		$ 39,159,658
United States [Member]
Concentration Risk [Line Items]
Revenue	1,225,910	641,646
Non-current tangible assets	38,330,741		38,803,333
International [Member]
Concentration Risk [Line Items]
Revenue	133,431	$ 96,055
Non-current tangible assets	$ 316,862		$ 355,825

Risk Concentrations - Additiona

Risk Concentrations - Additional Information (Details)	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
No Vendor [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage				10.00%
Gold Medal Group [Member] | Gold Medal Holdings [Member]
Concentration Risk [Line Items]
Ownership Percentage by Parent	40.00%		40.00%
Sales Revenue, Net [Member] | Customer One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage			10.00%	10.00%
Sales Revenue, Net [Member] | Gold Medal Group [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage			35.90%	34.60%
Accounts Receivable [Member] | Customer One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%	10.00%
Accounts Receivable [Member] | Gold Medal Group [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	74.80%	58.90%
Accounts Payable [Member] | Vendor One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%	10.00%
Accounts Payable [Member] | Gold Medal Group [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	45.50%	54.40%
Cost Of Revenue [Member] | Vendor One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage			10.00%
Cost Of Revenue [Member] | Gold Medal Group [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage			24.50%

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - Settled litigation - Litigation for alleged breach of contract and unjust enrichment on the company's resource recovery facility	Mar. 12, 2020USD ($)
Total amount payable	$ 775,000
Amount payable on the execution of the settlement agreement	$ 475,000
Execution period for the settlement agreement	60 days
Amount payable as monthly installments	$ 25,000
Number of installment months	12 months

Leases (Details)

Leases (Details)	Mar. 31, 2020USD ($)
Leases
2020 (remaining)	$ 95,521
2021	109,000
2022	113,000
2023	113,000
2024 and thereafter	2,980,750
Total lease payments	3,411,271
Less imputed interest	(2,372,788)
Present value of lease liabilities	$ 1,038,483

Leases - Additional Information

Leases - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Lessee, Lease, Description [Line Items]
Operating Lease Renewal Term	5 years
operating lease cost	$ 298,803	$ 0
Current portion of lease liabilities	121,510
Operating cash flow for operating leases	$ 51,406	46,034
Land Lease [Member]
Lessee, Lease, Description [Line Items]
Operating lease initial term	30 years
Leases utilization percentage	11.00%
Other Lease [Member]
Lessee, Lease, Description [Line Items]
Leases utilization percentage	10.25%
Research And Development Lease [Member]
Lessee, Lease, Description [Line Items]
operating lease cost	$ 55,356	$ 67,532
Weighted average remaining term (in years)	25 years 7 months 6 days

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Assets:
Accounts receivable	$ 2,485,691		$ 2,155,921
Liabilities:
Accounts payable	5,378,697		4,688,339
Accrued interest payable	558,624		1,148,570
Long term accrued interest	1,567,311		1,510,193
Advances from related parties	1,410,000		210,000
Other:
HEBioT revenue	406,958	$ 0
Operating expenses - HEBioT	298,803	0
Operating expenses - Selling, general and administrative	25,156	24,537
Interest expense	97,948	63,628
Related Party [Member]
Assets:
Accounts receivable	1,860,171		1,370,867
Intangible assets, net, included in other assets	35,349		40,399
Liabilities:
Accounts payable	2,654,592		2,531,034
Accrued interest payable	101,907		46,796
Long term accrued interest	1,567,311		1,510,193
Advances from related parties	1,410,000		210,000
Junior promissory note	954,885		949,434
Other:
Line of credit guarantee	1,481,356		$ 1,479,848
Technology Service [Member]
Other:
Operating expenses - Selling, general and administrative	110,650	18,750
Debt guarantee fees [Member]
Other:
Revenue from Contract with Customer, Including Assessed Tax	16,875	16,875
Management Advisory Fees [Member]
Other:
Revenue from Contract with Customer, Including Assessed Tax	$ 75,000	$ 250,000

Related Party Transaction - Add

Related Party Transaction - Additional Information (Details)	3 Months Ended
	Mar. 31, 2020USD ($)
Related Party Transaction [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	5.00%
Chief Executive Officer
Related Party Transaction [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	13.00%
Proceeds from Related Party Debt	$ 1,000,000
Other Officer [Member]
Related Party Transaction [Line Items]
Proceeds from Related Party Debt	$ 200,000
Refuel America LLC [Member]
Related Party Transaction [Line Items]
Equity Method Investment, Ownership Percentage	40.00%

Supplemental Consolidated Sta_3

Supplemental Consolidated Statement of Cash Flows Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2018
Changes in operating assets and liabilities:
Accounts receivable	$ (324,890)	$ 48,266
Inventory	31,981	76,930
Prepaid expenses and other assets	(25,989)	(36,508)
Accounts payable	672,061	3,088,732
Accrued interest payable	(525,392)	(399,764)
Accrued expenses	(9,591)	(2,668,827)
Deferred revenue	11,977	12,142
Customer deposits	(38,000)	4,351
Net change in operating assets and liabilities	(207,843)	125,322
Supplementary cash flow information:
Interest	1,387,402	1,082,526
Income taxes	0	0
Supplementary Disclosure of Non-Cash Investing and Financing Activities:
Transfer of inventory to leased equipment	67,604	6,884
Accrual of Series A preferred stock dividends	17,564	18,372
Payment of Series A preferred stock dividends in common stock	25,000	0
Reconciliation of Cash and Restricted Cash:
Cash	1,934,846	1,374,564	$ 1,847,526
Restricted cash (current)	1,137,714	2,137,456	1,133,581
Restricted cash (non-current)	2,563,978	2,532,933
Total cash and restricted cash at the end of the period	$ 5,636,538	$ 6,044,953	$ 5,536,952	$ 9,126,380

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	May 13, 2020	Apr. 27, 2020	Apr. 01, 2020	Mar. 31, 2020	Apr. 06, 2020	Mar. 18, 2020	Jan. 30, 2020	Dec. 31, 2019
Subsequent Event [Line Items]
Advance from related party				$ 1,410,000				$ 210,000
Preferred Stock Initial Closing Cost						$ 1,500,000
Preferred Stock New Series Shares						13,045
Common Stock Warrants					7,750	178,597
Reduction in scope and annual fee per year				$ 300,000
Series F Redeemable, Convertible Preferred Stock [Member]
Subsequent Event [Line Items]
Preferred Stock Initial Closing Cost					$ 65,000
Preferred Stock New Series Shares					566
Chief Executive Officer
Subsequent Event [Line Items]
Advance from related party							$ 1,050,000
Officer
Subsequent Event [Line Items]
Advance from related party							$ 200,000
Subsequent events
Subsequent Event [Line Items]
Application amount approved and funded under paycheck protection program	$ 421,300
Reduction in scope and annual fee per year			$ 100,000
Subsequent events | Chief Executive Officer
Subsequent Event [Line Items]
Repayment of related party advances		$ 275,000
Subsequent events | Officer
Subsequent Event [Line Items]
Repayment of related party advances		$ 200,000

Condensed Consolidating Finan_3

Condensed Consolidating Financial Information (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Current Assets
Cash	$ 1,934,846	$ 1,847,526
Restricted Cash	1,137,714	1,133,581
Other current assets	3,024,828	2,750,062
Current Assets	6,097,388	5,731,169
Restricted cash	2,563,978	2,555,845
HEBioT facility under construction, net	38,634,103	39,146,331
Operating lease right of use assets	918,585	945,047
MBT facility development and license costs	8,042,938	8,049,929
Investment in subsidiaries and intercompany accounts	0	0
Goodwill	58,000	58,000
Other assets	48,849	53,726
Total Assets	56,363,841	56,540,047
Liabilities, Current [Abstract]
Line of credit	1,481,356	1,479,848
Current portion of Debts and Bonds	2,860,000	1,390,000
Current portion of Debts and Bonds	7,101,578
Other current liabilities	9,427,785	8,213,007
Total Current Liabilities	18,010,719	11,082,855
Notes payable and other debts	962,011	5,118,125
Accrued interest	1,567,311	1,510,193
Non-current lease liabilities	916,973	915,170
WV EDA bonds	28,392,733	29,817,426
Total Liabilities	49,849,747	48,443,769
Redeemable preferred stock	726,553	726,553
Stockholders' equity :
Attributable to parent	1,264,636	2,024,143	$ 2,486,715	$ 3,405,551
Attributable to non-controlling interests	4,522,905	5,345,582	$ 6,290,994	$ 6,602,695
Stockholders' equity	5,787,541	7,369,725
Total liabilities and stockholders' equity	56,363,841	56,540,047
Consolidation, Eliminations [Member]
Current Assets
Cash	0	0
Restricted Cash	0	0
Other current assets	(123,459)	(64,669)
Current Assets	(123,459)	(64,669)
Restricted cash	0	0
HEBioT facility under construction, net	0	0
Operating lease right of use assets	0	0
MBT facility development and license costs	0	0
Investment in subsidiaries and intercompany accounts	(10,618,962)	(10,864,783)
Goodwill	0	0
Other assets	0	0
Total Assets	(10,742,421)	(10,929,452)
Liabilities, Current [Abstract]
Line of credit	0	0
Current portion of Debts and Bonds		0
Current portion of Debts and Bonds	0
Other current liabilities	0	(650,894)
Total Current Liabilities	0	(650,894)
Notes payable and other debts	0	0
Accrued interest	0	0
Non-current lease liabilities	0	0
WV EDA bonds	0	0
Total Liabilities	0	(650,894)
Redeemable preferred stock	0	0
Stockholders' equity :
Attributable to parent	0	0
Attributable to non-controlling interests	(10,742,421)	(10,278,558)
Stockholders' equity	(10,742,421)	(10,278,558)
Total liabilities and stockholders' equity	(10,742,421)	(10,929,452)
Entsorga West Virginia LLC [Member]
Current Assets
Cash	17,043	0
Restricted Cash	1,137,714	1,133,581
Other current assets	1,507,533	1,116,821
Current Assets	2,662,290	2,250,402
Restricted cash	2,563,978	2,555,845
HEBioT facility under construction, net	36,951,832	37,392,601
Operating lease right of use assets	894,260	897,026
MBT facility development and license costs	1,764,000	1,795,500
Investment in subsidiaries and intercompany accounts	(2,450,776)	0
Goodwill	58,000	58,000
Other assets	0	0
Total Assets	42,443,584	44,949,374
Liabilities, Current [Abstract]
Line of credit	0	0
Current portion of Debts and Bonds		1,390,000
Current portion of Debts and Bonds	2,860,000
Other current liabilities	5,637,288	6,475,985
Total Current Liabilities	8,497,288	7,865,985
Notes payable and other debts	0	0
Accrued interest	0	0
Non-current lease liabilities	916,973	915,170
WV EDA bonds	28,392,733	29,817,426
Total Liabilities	37,806,994	38,598,581
Redeemable preferred stock	0	0
Stockholders' equity :
Attributable to parent	0	0
Attributable to non-controlling interests	4,636,590	6,350,793
Stockholders' equity	4,636,590	6,350,793
Total liabilities and stockholders' equity	42,443,584	44,949,374
Parent Company [Member]
Current Assets
Cash	1,917,803	1,847,526
Restricted Cash	0	0
Other current assets	1,640,754	1,697,910
Current Assets	3,558,557	3,545,436
Restricted cash	0	0
HEBioT facility under construction, net	1,682,271	1,753,730
Operating lease right of use assets	24,325	48,021
MBT facility development and license costs	6,278,938	6,254,429
Investment in subsidiaries and intercompany accounts	13,069,738	10,864,783
Goodwill	0	0
Other assets	48,849	53,726
Total Assets	24,662,678	22,520,125
Liabilities, Current [Abstract]
Line of credit	1,481,356	1,479,848
Current portion of Debts and Bonds		0
Current portion of Debts and Bonds	4,241,578
Other current liabilities	3,790,497	2,387,916
Total Current Liabilities	9,513,431	3,867,764
Notes payable and other debts	962,011	5,118,125
Accrued interest	1,567,311	1,510,193
Non-current lease liabilities	0	0
WV EDA bonds	0	0
Total Liabilities	12,042,753	10,496,082
Redeemable preferred stock	726,553	726,553
Stockholders' equity :
Attributable to parent	1,264,636	2,024,143
Attributable to non-controlling interests	10,628,736	9,273,347
Stockholders' equity	11,893,372	11,297,490
Total liabilities and stockholders' equity	$ 24,662,678	$ 22,520,125

Condensed Consolidating Finan_4

Condensed Consolidating Financial Information - Statement of Operations (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenues	$ 1,359,341	$ 737,701
Cost of revenue	25,156	24,537
Operating Expenses [Abstract]
Selling, general and administrative	1,918,423	2,326,362
Depreciation and amortization	615,202	129,439
Total operating expenses	3,753,291	2,659,004
Loss from operations	(2,393,950)	(1,921,303)
Other (income) expenses, net	1,000,024	339,864
Net loss	(3,393,974)	(2,261,167)
Consolidation, Eliminations [Member]
Revenues	0	0
Operating Expenses [Abstract]
Selling, general and administrative	0	0
Depreciation and amortization	0	0
Total operating expenses	0	0
Loss from operations	0	0
Other (income) expenses, net	0	0
Net loss	0	0
Entsorga West Virginia LLC [Member]
Revenues	490,132	0
Operating Expenses [Abstract]
Selling, general and administrative	249,643	269,115
Depreciation and amortization	490,469	0
Total operating expenses	1,552,539	269,115
Loss from operations	(1,062,407)	(269,115)
Other (income) expenses, net	651,796	27,875
Net loss	(1,714,203)	(296,990)
Parent Company [Member]
Revenues	869,209	737,701
Operating Expenses [Abstract]
Selling, general and administrative	1,668,780	2,057,247
Depreciation and amortization	124,733	129,439
Total operating expenses	2,200,752	2,389,889
Loss from operations	(1,331,543)	(1,652,188)
Other (income) expenses, net	348,228	311,989
Net loss	(1,679,771)	(1,964,177)
HEBioT (related entity)
Cost of revenue	812,427	0
HEBioT (related entity) | Consolidation, Eliminations [Member]
Cost of revenue	0
HEBioT (related entity) | Entsorga West Virginia LLC [Member]
Cost of revenue	812,427
HEBioT (related entity) | Parent Company [Member]
Cost of revenue	0
Rental, service and maintenance
Cost of revenue	260,835	203,203
Rental, service and maintenance | Consolidation, Eliminations [Member]
Cost of revenue	0	0
Rental, service and maintenance | Entsorga West Virginia LLC [Member]
Cost of revenue	0	0
Rental, service and maintenance | Parent Company [Member]
Cost of revenue	260,835	203,203
Equipment sales
Cost of revenue	146,404	$ 0
Equipment sales | Consolidation, Eliminations [Member]
Cost of revenue	0
Equipment sales | Entsorga West Virginia LLC [Member]
Cost of revenue	0
Equipment sales | Parent Company [Member]
Cost of revenue	$ 146,404

Condensed Consolidating Finan_5

Condensed Consolidating Financial Information - Statement of Cash Flow (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net loss	$ (3,393,974)	$ (2,261,167)
Non-cash adjustments to reconcile net loss to net cash used in operations	1,086,343	923,196
Changes in operating assets and liabilities	(207,843)	125,322
Net cash used in operations	(2,515,474)	(1,212,649)
Cash flow from investing activities:
Purchases of construction in-progress, equipment, fixtures and vehicles	(20,849)	(2,794,824)
Capital contribution to Entsorga West Virginia, LLC		0
Other investing activities	(24,509)	(52,400)
Net cash used in investing activities	(45,358)	(2,742,424)
Cash flows from financing activities:
Issuances of debt and equity	2,695,450	900,000
Repayments of debt	(1,460)	(2,264)
Deferred financing costs incurred		(43,941)
Net cash provided by financing activities	2,693,990	853,795
Effect of exchange rate on cash (restricted and unrestricted)	(33,572)	19,851
Cash - beginning of period (restricted and unrestricted)	5,536,952	9,126,380
Cash - end of period (restricted and unrestricted)	5,636,538	6,044,953
Consolidation, Eliminations [Member]
Cash flows from operating activities:
Net loss	0	0
Non-cash adjustments to reconcile net loss to net cash used in operations	0	0
Changes in operating assets and liabilities	0	0
Net cash used in operations	0	0
Cash flow from investing activities:
Purchases of construction in-progress, equipment, fixtures and vehicles	0	0
Capital contribution to Entsorga West Virginia, LLC		1,000,000
Other investing activities	0	0
Net cash used in investing activities	0	1,000,000
Cash flows from financing activities:
Issuances of debt and equity	0	(1,000,000)
Repayments of debt	0	0
Deferred financing costs incurred		0
Net cash provided by financing activities	0	(1,000,000)
Effect of exchange rate on cash (restricted and unrestricted)	0	0
Cash - beginning of period (restricted and unrestricted)	0	0
Cash - end of period (restricted and unrestricted)	0	0
Entsorga West Virginia LLC [Member]
Cash flows from operating activities:
Net loss	(1,714,203)	(296,990)
Non-cash adjustments to reconcile net loss to net cash used in operations	535,776	31,090
Changes in operating assets and liabilities	1,225,938	61,590
Net cash used in operations	47,511	(204,310)
Cash flow from investing activities:
Purchases of construction in-progress, equipment, fixtures and vehicles	(18,200)	(2,795,012)
Capital contribution to Entsorga West Virginia, LLC		0
Other investing activities	0	0
Net cash used in investing activities	(18,200)	(2,795,012)
Cash flows from financing activities:
Issuances of debt and equity	0	1,000,000
Repayments of debt	0	0
Deferred financing costs incurred		(43,941)
Net cash provided by financing activities	0	956,059
Effect of exchange rate on cash (restricted and unrestricted)	0	0
Cash - beginning of period (restricted and unrestricted)	3,689,426	6,715,672
Cash - end of period (restricted and unrestricted)	3,718,735	4,672,409
Parent Company [Member]
Cash flows from operating activities:
Net loss	(1,679,771)	(1,964,177)
Non-cash adjustments to reconcile net loss to net cash used in operations	550,567	892,106
Changes in operating assets and liabilities	(1,433,781)	63,732
Net cash used in operations	(2,562,985)	(1,008,339)
Cash flow from investing activities:
Purchases of construction in-progress, equipment, fixtures and vehicles	(2,649)	188
Capital contribution to Entsorga West Virginia, LLC		(1,000,000)
Other investing activities	(24,509)	(52,400)
Net cash used in investing activities	(27,158)	(947,412)
Cash flows from financing activities:
Issuances of debt and equity	2,695,450	900,000
Repayments of debt	(1,460)	(2,264)
Deferred financing costs incurred		0
Net cash provided by financing activities	2,693,990	897,736
Effect of exchange rate on cash (restricted and unrestricted)	(33,572)	19,851
Cash - beginning of period (restricted and unrestricted)	1,847,526	2,410,708
Cash - end of period (restricted and unrestricted)	$ 1,917,803	$ 1,372,544